Integrated sample processing system with multiple detection capabilities - Patents.com
An integrated sample processing system with a mass spectrometer and immunoanalyzer simplifies sample preparation, enhancing analytical accuracy and throughput, addressing barriers to clinical adoption of mass spectrometry.
Patent Information
- Application Number
- JP2023037413
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-12-19
- Filing Date
- 2023-03-10
- Publication Date
- 2024-12-04
- Estimated Expiration
- 2038-05-22
AI Technical Summary
Mass spectrometry has not found widespread clinical use due to challenges such as sample preparation, online extraction, throughput, automation, laboratory information system interfaces, and interinstrument standardization and harmonization.
An integrated sample processing system that includes a chemical or immunoanalyzer integrated with a mass spectrometer, featuring a common sample preparation station and multiple detection systems, including optical detection, which simplifies sample preparation by eliminating centrifugation and LC systems, improving robustness and turnaround time.
The system enhances analytical accuracy and reduces complexity by streamlining sample preparation, improving throughput, and facilitating automation, thereby making mass spectrometry more suitable for clinical use.
Smart Images

Figure 0007594618000001 
Figure 0007594618000002 
Figure 0007594618000003
Abstract
Description
[Technical field]
[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application is a nonprovisional application of and claims the benefit of the filing dates of U.S. Patent Application Nos. 62 / 509,601, filed May 22, 2017, and 62 / 607,773, filed December 19, 2017, which are hereby incorporated by reference in their entirety for all purposes. [Background technology]
[0002] Mass spectrometry (MS) is an analytical technique used to determine the elemental composition of samples, quantify the mass of particles and molecules, and elucidate the chemical structure of molecules. Various types of MS with high specificity, such as liquid chromatography (LC-MS), gas chromatography (GC-MS), and matrix-assisted laser desorption / ionization / time-of-flight (MALDI-TOF MS), have been used in clinical diagnostics. These MS techniques overcome many of the limitations of immunoassays (e.g., nonspecific binding and cross-reactivity of analytes) and offer many advantages.
[0003] To date, MS technology has not found widespread clinical application due to challenges such as sample preparation, on-line extraction, throughput, automation, laboratory information system interfacing, inter-instrument standardization and harmonization.
[0004] Embodiments of the present invention address these and other problems, either individually or collectively. Summary of the Invention [Means for solving the problem]
[0005] Some embodiments of the present invention may include an integrated sample processing system that may include an analyzer, such as a chemical analyzer or an immunoanalyzer, integrated with a mass spectrometer. Embodiments of the present invention provide the advantage of having a common sample preparation station with the option of using multiple detection systems. Such detection systems may include an optical detection system that may be present in the mass spectrometer and the analyzer. The optical detection system may operate using an immunoassay detection process, such as chemiluminescence or fluorescence.
[0006] The embodiments of the present invention may also include mass spectrometry systems and methods for analyzing small and large molecules (proteins). In some embodiments, the workflow from sample preparation to detection is simplified compared to conventional sample preparation methods. The simplified sample preparation methods according to the embodiments of the present invention do not require the use of centrifugation and / or LC systems. Eliminating the centrifuge and LC system in the sample processing system reduces complexity, improves the robustness of the overall sample analysis process, improves the TAT (turnaround time) of the processed samples, and / or improves or maintains the accuracy of the analysis of the processed samples.
[0007] One embodiment of the present invention relates to a sample processing system comprising an analyzer including: (i) a sample presentation unit configured to hold a plurality of sample tubes containing samples; (ii) an aliquot station including a pipettor and configured to provide a sample aliquot in a sample tube in the plurality of sample tubes to a reaction vessel; and (iii) an optical detection station configured to detect an analyte in a first processed sample aliquot of the sample in the reaction vessel using the pipettor. A mass spectrometer may be coupled to the analyzer. The mass spectrometer is configured to receive a second processed sample aliquot from the analyzer and detect an analyte in the received second processed sample aliquot. The sample processing system may include a control system configured to control the analyzer and the mass spectrometer.
[0008] Another embodiment of the invention relates to a method implemented by a sample processing system including an analyzer including an aliquot station including at least one pipettor, a mass spectrometer, a sample introduction device, and a control system. The control system may be operatively coupled to the analyzer, the mass spectrometer, and the sample introduction device. The method includes providing a first sample aliquot of a sample and a second sample aliquot of a sample by at least one pipettor of the aliquot station, processing the first sample aliquot of the sample by multiple processing devices in the analyzer to form a first processed sample aliquot, processing the second sample aliquot of the sample by multiple processing devices in the analyzer to form a second processed sample aliquot, performing a process by the analyzer to detect an analyte in the first processed sample aliquot using an immunoanalyzer, transferring the second processed sample aliquot from the analyzer to a mass spectrometer by the sample introduction device, and detecting the analyte or another analyte in the second processed sample aliquot using the mass spectrometer.
[0009] Another embodiment of the invention is a method performed by a sample processing system comprising an analyzer including an aliquot station including at least one pipettor, a mass spectrometer, a sample introduction device, and a control system operatively coupled to the analyzer, the mass spectrometer, the sample introduction device, and the control system, the method comprising: providing a first sample aliquot of the sample and a second sample aliquot of the sample by at least one pipettor of the aliquot station; performing a primary analysis of analytes in a first processed sample aliquot derived from the first sample aliquot of the sample in a reaction vessel by the analyzer; transferring a second processed sample aliquot derived from the second sample aliquot of the sample from the analyzer to the mass spectrometer by the sample introduction device; and performing a secondary analysis of the analyte in the second processed sample aliquot or another analyte in a secondary analysis by a mass spectrometer.
[0010] Another embodiment of the present invention relates to a sample processing system comprising an analyzer including an aliquot station, a mass spectrometer coupled to the analyzer, a sample introduction device coupled to the analyzer and the mass spectrometer, and a control system coupled to the analyzer, the mass spectrometer, and the sample introduction device, the control system including a processor and a computer readable medium. The computer readable medium includes code executable by a processor to perform a method including instructing an aliquot station including at least one pipettor to provide a first sample aliquot of the sample and a second sample aliquot of the sample; instructing an analyzer to process a reaction vessel containing the first sample aliquot of the sample to form a first processed sample aliquot; instructing the analyzer to perform a primary analysis of an analyte in the first processed sample aliquot; instructing the analyzer to process the second aliquot of the sample to form a second processed sample aliquot; instructing a sample introduction device to transfer the second processed sample aliquot of the sample from the analyzer to a mass spectrometer; and instructing the mass spectrometer to perform a secondary analysis of the analyte in the second processed sample aliquot or another analyte.
[0011] Another embodiment of the invention relates to a method of performing an analysis, the method being performed by a sample processing system comprising an analyzer, a mass spectrometer, a sample introduction device, and a control system operatively coupled to the analyzer, the mass spectrometer, the sample introduction device, and the control system. The method includes performing, by the analyzer, a primary analysis of a first biomarker for a disease in a first processed sample aliquot derived from a first sample aliquot of a sample in a reaction vessel, transferring, by the sample introduction device, a second processed sample aliquot derived from a second sample aliquot of the sample from the analyzer to a mass spectrometer, and performing, by the mass spectrometer, a secondary analysis of a second biomarker for the disease in the second processed sample aliquot in a secondary analysis.
[0012] Another embodiment of the present invention relates to a sample processing system comprising an analyzer including: (i) a sample presentation unit configured to hold a plurality of sample tubes containing a sample; (ii) an aliquot station configured to provide a first aliquot of the sample to a reaction vessel including an analyte in a sample tube in the plurality of sample tubes and to provide a second aliquot; and (iii) an optical detection station configured to detect the analyte in the first processed sample aliquot of the sample in the reaction vessel; a mass spectrometer coupled to the analyzer, the mass spectrometer configured to receive a second processed sample aliquot derived from the second aliquot from the analyzer and to detect the analyte in the received second processed sample aliquot; and a control system configured to control the analyzer and the mass spectrometer.
[0013] Another embodiment of the invention relates to a method performed by a sample processing system comprising an analyzer, a mass spectrometer, a sample introduction device, and a control system operatively coupled to the analyzer, the mass spectrometer, the sample introduction device, and the control system, the method including performing, by the analyzer, a primary analysis of an analyte in a first processed sample aliquot derived from a first sample aliquot of a sample in a reaction vessel, determining whether a concentration of the analyte in the first processed sample aliquot is below, above, or equal to a predetermined threshold, transferring, by the sample introduction device, a second processed sample aliquot derived from a second sample aliquot of the sample from the analyzer to a mass spectrometer, and performing, by the mass spectrometer, a secondary analysis of the analyte in the second processed sample aliquot or another analyte in the secondary analysis.
[0014] Another embodiment of the invention relates to a sample processing system comprising an analyzer including: (i) a sample presentation unit configured to hold a plurality of sample tubes containing samples, (ii) an aliquot station configured to provide a sample aliquot to a reaction vessel including an analyte in a sample tube in the plurality of sample tubes, and (iii) an optical detection station configured to detect an analyte in a first processed sample aliquot of the sample in the reaction vessel, a mass spectrometer coupled to the analyzer, the mass spectrometer configured to receive the first and / or second processed sample aliquots from the analyzer and detect the analyte in the first and / or second processed sample aliquots, and a control system configured to control the analyzer and the mass spectrometer. The control system includes a data processor and a computer readable medium, the computer readable medium including code executable by the data processor to perform the method. The method includes using data from the optical detection station to determine whether detection of the analyte in the first processed sample aliquot at the optical detection station is below, above, or equal to a predetermined threshold, and in response to the determination, causing an analyzer to process a second sample aliquot to form a second processed sample aliquot, causing a sample introduction device to transfer the second processed sample aliquot from the analyzer to a mass spectrometer, and causing the mass spectrometer to detect the presence of the analyte or another analyte in the second processed sample aliquot.
[0015] Another embodiment of the invention relates to a method performed by a sample processing system comprising at least a mass spectrometer, a sample introduction device, and a control system operatively coupled to the mass spectrometer and the sample introduction device, the method including performing a primary analysis of an analyte from a first processed sample aliquot of a first sample aliquot of a sample by the mass spectrometer, and performing a secondary analysis of the analyte or another analyte in a second processed sample aliquot derived from a second aliquot of the sample by a mass spectrometer or analyzer in the sample processing system after performing the primary analysis.
[0016] Another embodiment of the invention relates to a sample processing system comprising a mass spectrometer, a sample introduction device, and a control system, the control system controlling the operation of the mass spectrometer and the sample introduction device, and the control system including a processor and a computer readable medium. The computer readable medium includes code executable by the processor to perform a method including performing, by the mass spectrometer, a primary analysis of an analyte from a first processed sample aliquot of a first sample aliquot of a sample, and performing, after performing the primary analysis, a secondary analysis of the analyte or another analyte in a second processed sample aliquot derived from a second aliquot of the sample, by a mass spectrometer or analyzer in the sample processing system. The present invention provides, for example, the following: (Item 1) an analyzer comprising: (i) a sample presentation unit configured to hold a plurality of sample tubes containing samples; (ii) an aliquot station including at least one pipettor configured to present a first sample aliquot of a sample containing an analyte in a sample tube in the plurality of sample tubes to a reaction vessel and to present a second aliquot; and (iii) an optical detection station configured to detect the analyte in the first processed sample aliquot of the sample in the reaction vessel; a mass spectrometer coupled to the analyzer, the mass spectrometer configured to receive a second processed sample aliquot from the analyzer, the second processed sample aliquot being derived from the second sample aliquot, and to detect the analyte in the second processed sample aliquot; a control system configured to control the analyzer and the mass spectrometer. (Item 2) the aliquot of the sample is a first sample aliquot, and the sample processing system further comprises: a plurality of sample aliquot processing devices within the analyzer, the plurality of sample aliquot processing devices being capable of processing the first sample aliquot to form the first processed sample aliquot and capable of processing a second sample aliquot of the sample to form the second processed sample aliquot; 2. The sample processing system of claim 1, further comprising: a sample introduction device coupled to the control system, the analyzer, and the mass spectrometer, the sample introduction device configured to transfer the second processed sample aliquot from the analyzer to the mass spectrometer. (Item 3) the sample aliquot is a first sample aliquot, and the control system A data processor; 1. A computer-readable medium, comprising: using data from the optical detection station to determine whether detection of the analyte in the first processed sample aliquot at the optical detection station is below, above, or equal to a predetermined threshold; in response to the determination, causing the analyzer to process the second sample aliquot to form the second processed sample aliquot and causing the sample introduction device to transfer the second processed sample aliquot from the analyzer to the mass spectrometer; and causing the mass spectrometer to detect the presence of the analyte or another analyte in the second processed sample aliquot. (Item 4) 3. The sample processing system of claim 2, wherein the sample introduction device comprises a pick-and-place device, a transfer shuttle, a trap and elute device, an open port device, or a direct injection device. (Item 5) 2. The sample processing system of claim 1, wherein the analyzer further comprises a sample storage unit configured to store another reaction vessel containing another aliquot of the sample. (Item 6) 2. The sample processing system of claim 1, wherein the mass spectrometer, the analyzer, and the control system are integrally connected within a single instrument. (Item 7) 2. The sample processing system of claim 1, wherein the analyzer further includes a reagent storage section, the reagent storage section including a plurality of reagent packs, including a first plurality of reagent packs including reagents for performing an immunoassay, and a second plurality of reagent packs including reagents for performing mass spectrometry in the mass spectrometer. (Item 8) The analyzer is an immunochemical analyzer, the analyzer comprising: 2. The sample processing system of claim 1, further comprising a reagent dispensing station configured to dispense one or more reagents into the reaction vessel containing the sample aliquot. (Item 9) 2. The sample processing system of claim 1, wherein the analyzer further comprises a separation station including a magnet, the magnet being for separating the analyte from other components in the sample in the reaction vessel. (Item 10) the sample aliquot is a first sample aliquot, the reaction vessel is a first reaction vessel, and the sample processing system comprises: a plurality of sample aliquot processing devices within the analyzer, the plurality of sample aliquot processing devices being capable of processing the first sample aliquot to form the first processed sample aliquot and capable of processing a second sample aliquot of the sample to form the second processed sample aliquot; The control system includes: A data processor; 1. A computer-readable medium, comprising: causing the optical detection station to detect the analyte in the first processed sample aliquot; and causing the mass spectrometer to detect the analyte in the second processed sample aliquot transferred from the analyzer. (Item 11) 1. A method performed by a sample processing system comprising an analyzer including an aliquot station including at least one pipettor, a mass spectrometer, a sample introduction device, and a control system, the control system operatively coupled to the analyzer, the mass spectrometer, the sample introduction device, and the control system, the method comprising: providing, by the at least one pipettor of the aliquot station, a first sample aliquot of a sample and a second sample aliquot of the sample; processing the first sample aliquot of a sample with one or more of a plurality of processing devices within the analyzer to form a first processed sample aliquot; processing the second sample aliquot of the sample with one or more of the plurality of processing devices within the analyzer to form a second processed sample aliquot; performing, by the analyzer, a process for detecting an analyte in the first processed sample aliquot using the analyzer; transferring the second processed sample aliquot from the analyzer to the mass spectrometer by the sample introduction device; detecting the analyte or another analyte in the second processed sample aliquot using the mass spectrometer. (Item 12) Item 12. The method of item 11, wherein the plurality of processing devices includes two or more of a pipetting station, a reagent dispensing station, an incubator, and a washing and separation station. (Item 13) 12. The method of claim 11, wherein the process for detecting comprises detecting the amount or presence of the analyte using the analyzer, and the process of detecting the analyte by the mass spectrometer also comprises detecting the amount or presence of the analyte. (Item 14) Processing the first sample aliquot comprises: dispensing a reagent into a reaction vessel containing the first sample aliquot; incubating the reaction vessel containing the reagent and the sample aliquot; and separating the analyte from other components in the first sample aliquot using a washing and magnetic separation process. (Item 15) 12. The method of claim 11, wherein the sample is a biological fluid. (Item 16) 12. The method of claim 11, wherein transferring the sample from the analyzer to the mass spectrometer comprises injecting the sample into the mass spectrometer by the sample introduction device. (Item 17) 12. The method of claim 11, wherein transferring the second processed sample aliquot from the analyzer to the mass spectrometer comprises transferring the second processed sample aliquot by the sample introduction device using a trap and elute system. (Item 18) 12. The method of claim 11, wherein processing the second processed sample aliquot by the analyzer comprises derivatizing the analyte in the second processed sample aliquot. (Item 19) 12. The method of claim 11, further comprising storing the second sample aliquot in a reaction vessel in a sample storage unit. (Item 20) 12. The method of claim 11, wherein the method does not utilize a high pressure liquid chromatography column or a centrifuge. (Item 21) 1. A method performed by a sample processing system comprising: an analyzer including an aliquot station including at least one pipettor; a mass spectrometer; a sample introduction device; and a control system, the control system operatively coupled to the analyzer, the mass spectrometer, the sample introduction device, and the control system, the method comprising: providing, by the at least one pipettor of the aliquot station, a first sample aliquot of a sample and a second sample aliquot of the sample; performing, by the analyzer, a primary analysis of an analyte in a first processed sample aliquot derived from the first sample aliquot of a sample in a reaction vessel; transferring a second processed sample aliquot derived from the second sample aliquot of the sample from the analyzer to the mass spectrometer by the sample introduction device; and performing a secondary analysis of the analyte or another analyte in the second processed sample aliquot in a secondary analysis by a mass spectrometer. (Item 22) 22. The method of claim 21, further comprising processing the first sample aliquot in a first reaction vessel by the analyzer such that the primary analysis can be performed. (Item 23) 22. The method of claim 21, further comprising processing the second sample aliquot in a second reaction vessel by the analyzer to prepare the second sample aliquot for the mass spectrometer. (Item 24) Prior to transferring the second processed sample aliquot from the analyzer to the mass spectrometer by the sample introduction device, the method further comprises: 22. The method of claim 21, further comprising determining, by the control system, whether a concentration of an analyte in the first processed sample aliquot is below, above, or equal to a predetermined threshold prior to producing the second processed sample aliquot. (Item 25) 25. The method of claim 24, wherein the concentration of the analyte in the first processed sample aliquot is less than or equal to a predetermined threshold. (Item 26) 23. The method of claim 22, further comprising performing an immunopurification process on the second sample aliquot. (Item 27) 23. The method of claim 22, further comprising obtaining an additional sample aliquot from the sample and storing the additional sample aliquot in a sample storage unit. (Item 28) 24. The method of claim 23, wherein the analyzer comprises a magnetic washing station. (Item 29) 30. The method of claim 28, wherein processing the second sample aliquot comprises using a magnetic separation process in the magnetic washing station to separate the analytes from other components in the second sample aliquot. (Item 30) 22. The method of claim 21, wherein the sample introduction device comprises a trap and elution system. (Item 31) 22. The method of claim 21, wherein transferring the second processed sample aliquot from the analyzer to the mass spectrometer comprises injecting the second processed sample aliquot from the analyzer into the mass spectrometer. (Item 32) 22. The method of claim 21, wherein the sample introduction device comprises an open port sample collection interface. (Item 33) an analyzer including an aliquot station; a mass spectrometer coupled to the analyzer; a sample introduction device coupled to the analyzer and the mass spectrometer; a control system coupled to the analyzer, the mass spectrometer, and the sample introduction device, the control system comprising a processor and a computer readable medium, the computer readable medium comprising a method, the method comprising: directing the aliquot station, the aliquot station including at least one pipettor, to provide a first sample aliquot of a sample and a second sample aliquot of the sample; directing the analyzer to process a reaction vessel containing the first sample aliquot of a sample to form a first processed sample aliquot; instructing the analyzer to perform a primary analysis of an analyte in the first processed sample aliquot; instructing the analyzer to process the second aliquot of the sample to form a second processed sample aliquot; directing the sample introduction device to transfer the second processed sample aliquot of the sample from the analyzer to the mass spectrometer; and a computer readable medium comprising code executable by the processor to perform a method comprising: instructing the mass spectrometer to perform a secondary analysis of the analyte or another analyte in the second processed sample aliquot. (Item 34) The method further comprising: 34. The sample processing system of claim 33, further comprising determining, by the control system, whether the primary analysis detects the presence or absence of the analyte according to a predetermined threshold. (Item 35) 35. The sample processing system of claim 34, wherein the predetermined threshold corresponds to a predetermined amount or a predetermined concentration of the analyte in the processed first sample aliquot. (Item 36) 34. The sample processing system of claim 33, wherein instructing the analyzer to process the second sample aliquot comprises instructing the analyzer to perform an immunopurification process on the second sample aliquot in a reaction vessel. (Item 37) 37. The sample processing system of claim 36, wherein the immunopurification process separates the analyte from other components in the second sample aliquot using a magnetic separation process. (Item 38) 34. The sample processing system of claim 33, wherein instructing the analyzer to process the second sample aliquot comprises instructing the analyzer to perform a protein precipitation process on the second sample aliquot. (Item 39) 40. The sample processing system of claim 38, wherein the protein precipitation process separates the analytes from other components in the second sample aliquot using a magnetic separation process. (Item 40) Item 34. The sample processing system of item 33, wherein the sample introduction device comprises a trap and elution system. (Item 41) 34. The sample processing system of claim 33, wherein instructing the sample introduction device to transfer the second processed sample aliquot of the sample from the analyzer to the mass spectrometer comprises instructing the sample introduction device to transfer the second processed sample aliquot of the sample from the analyzer to the mass spectrometer by injecting the second processed sample aliquot. (Item 42) Item 34. The sample processing system of item 33, wherein the sample introduction device comprises an open port sample collection interface. (Item 43) 1. A method of performing an analysis, the method being performed by a sample processing system comprising an analyzer, a mass spectrometer, a sample introduction device, and a control system, the control system operatively coupled to the analyzer, the mass spectrometer, the sample introduction device, and the control system, the method comprising: performing, by the analyzer, a primary analysis for a first biomarker for a disease in a first processed sample aliquot derived from a first sample aliquot of the sample in the reaction vessel; transferring a second processed sample aliquot derived from a second sample aliquot of the sample from the analyzer to the mass spectrometer by the sample introduction device; and performing a secondary analysis for a second biomarker for said disease in said second processed sample aliquot in a secondary analysis by a mass spectrometer. (Item 44) 44. The method of claim 43, wherein the analyzer comprises an immunoanalyzer and the primary analysis comprises performing an immunoanalysis using an optical detection process. (Item 45) 2. The sample processing system of claim 1, wherein the mass spectrometer is configured to receive the second processed sample aliquot from the analyzer and detect the analyte in the second processed sample aliquot, and the mass spectrometer is not configured to detect the analyte in the first processed sample aliquot. (Item 46) an analyzer comprising: (i) a sample presentation unit configured to hold a plurality of sample tubes containing samples; (ii) an aliquot station configured to present a first sample aliquot of a sample containing an analyte in a sample tube in the plurality of sample tubes to a reaction vessel and to provide a second aliquot; and (iii) an optical detection station configured to detect the analyte in the first processed sample aliquot of the sample in the reaction vessel; a mass spectrometer coupled to the analyzer, the mass spectrometer configured to receive a second processed sample aliquot from the analyzer derived from the second aliquot and to detect the analyte in the received second processed sample aliquot; a control system configured to control the analyzer and the mass spectrometer. (Item 47) 1. A method performed by a sample processing system comprising an analyzer, a mass spectrometer, a sample introduction device, and a control system, the control system operatively coupled to the analyzer, the mass spectrometer, the sample introduction device, and the control system, the method comprising: performing, by the analyzer, a primary analysis of an analyte in a first processed sample aliquot derived from a first sample aliquot of the sample in the reaction vessel; determining whether a concentration of an analyte in the first processed sample aliquot is below, above, or equal to a predetermined threshold; transferring a second processed sample aliquot derived from a second sample aliquot of the sample from the analyzer to the mass spectrometer by the sample introduction device; and performing a secondary analysis of the analyte or another analyte in the second processed sample aliquot in a secondary analysis by a mass spectrometer. (Item 48) 48. The method of claim 47, wherein the analyzer includes two or more of a pipetting station, a reagent dispensing station, an incubator, and a washing and separation station. (Item 49) 48. The method of claim 47, wherein the analyzer is an immunoanalyzer. (Item 50) Processing the first sample aliquot comprises: dispensing a reagent into a reaction vessel containing the first sample aliquot; incubating the reaction vessel containing the reagent and the sample aliquot; and separating the analyte from other components in the first sample aliquot using a washing and magnetic separation process. (Item 51) an analyzer comprising: (i) a sample presentation unit configured to hold a plurality of sample tubes containing a sample; (ii) an aliquot station configured to provide an aliquot of a sample to a reaction vessel, the aliquot including an analyte present in a sample tube in the plurality of sample tubes; and (iii) an optical detection station configured to detect the analyte in a first processed sample aliquot of the sample in the reaction vessel; a mass spectrometer coupled to the analyzer, the mass spectrometer configured to receive a first processed sample aliquot and / or a second processed sample aliquot from the analyzer and detect the analyte in the first processed sample aliquot and / or the second processed sample aliquot; A sample introduction device; A control system configured to control the analyzer, the sample introduction device, and the mass spectrometer, the control system comprising: A data processor; 1. A computer-readable medium, comprising: using data from the optical detection station to determine whether detection of the analyte in the first processed sample aliquot at the optical detection station is below, above, or equal to a predetermined threshold; in response to the determination, causing the analyzer to process the second sample aliquot to form a second processed sample aliquot and causing the sample introduction device to transfer the second processed sample aliquot from the analyzer to the mass spectrometer; and a control system including a computer readable medium including code executable by the data processor to perform a method comprising: causing the mass spectrometer to detect the presence of the analyte or another analyte in the second processed sample aliquot. (Item 52) The sample processing system comprises: a plurality of sample aliquot processing devices within the analyzer, the plurality of sample aliquot processing devices being capable of processing the first sample aliquot to form the first processed sample aliquot and capable of processing a second sample aliquot of the sample to form the second processed sample aliquot; 52. The sample processing system of claim 51, further comprising: an analyzer and a mass spectrometer, wherein the sample introduction device is configured to transfer the second processed sample aliquot from the analyzer to the mass spectrometer. (Item 53) 53. The sample processing system of item 52, wherein the sample introduction device comprises a pick-and-place device, a transfer shuttle, a trap and elute device, an open port device, or a direct injection device. (Item 54) 53. The sample processing system of claim 52, wherein the mass spectrometer, the analyzer, and the control system are integrally connected within a single instrument. (Item 55) 53. The sample processing system of claim 52, wherein the analyzer further comprises a reagent reservoir, the reagent reservoir including a plurality of reagent packs, including a first plurality of reagent packs including reagents for performing an immunoassay and a second plurality of reagent packs including reagents for performing mass spectrometry in the mass spectrometer. (Item 56) 1. A method implemented by a sample processing system comprising at least a mass spectrometer, a sample introduction device, and a control system, the control system operably coupled to the mass spectrometer and the sample introduction device, the method comprising: performing a primary analysis of an analyte from a first processed sample aliquot of a first sample aliquot of the sample with the mass spectrometer; After performing the primary analysis, performing a secondary analysis of the analyte or another analyte in a second processed sample aliquot derived from a second aliquot of the sample by the mass spectrometer or analyzer in the sample processing system. (Item 57) 57. The method of claim 56, wherein the sample processing system further comprises an analyzer comprising an immunoanalyzer. (Item 58) 57. The method of claim 56, wherein the analyte or another analyte comprises a steroid or a drug of abuse. (Item 59) 57. The method of claim 56, wherein the sample processing system further comprises an analyzer, the analyzer comprising an aliquot station. (Item 60) 57. The method of claim 56, wherein the analyte is one of many analytes in a panel of analytes that can be identified in the first processed sample aliquot in the first analysis. (Item 61) 57. The method of claim 56, wherein the sample processing system further comprises an analyzer, and the secondary analysis is performed by the analyzer. (Item 62) 57. The method of claim 56, wherein the secondary analysis is performed by a mass spectrometer. (Item 63) A mass spectrometer; A sample introduction device; A control system, the control system controlling operation of the mass spectrometer and the sample introduction device, the control system comprising a processor and a computer readable medium, the computer readable medium comprising a method, the method comprising: performing a primary analysis of an analyte from a first processed sample aliquot of a first sample aliquot of the sample with the mass spectrometer; and a control system including a computer readable medium including code executable by the processor to perform a method including: after performing the primary analysis, performing a secondary analysis of the analyte or another analyte in a second processed sample aliquot derived from a second aliquot of the sample by the mass spectrometer or analyzer in the sample processing system. (Item 64) Item 64. The sample processing system of item 63, further comprising an analyzer, the analyzer being an immunoanalyzer or a chemical analyzer. (Item 65) Item 65. The sample processing system of item 64, wherein the analyzer includes an aliquot station. (Item 66) 65. The sample processing system of claim 64, wherein the analyzer comprises reagents for performing mass spectrometry and reagents for performing immunoassay analysis. (Item 67) Item 65. The sample processing system of item 64, wherein the sample introduction device is configured to provide a processed sample aliquot from the analyzer to the mass spectrometer. (Item 68) 64. The sample processing system of claim 63, wherein the analyte is one of a number of analytes in a panel of analytes that can be identified in the first processed sample aliquot in the first analysis. (Item 69) 64. The sample processing system of claim 63, further comprising an analyzer, wherein the secondary analysis is performed by the analyzer. (Item 70) 64. The sample processing system of claim 63, wherein the secondary analysis is performed by a mass spectrometer.
[0017] These and other embodiments of the invention are described in further detail below with reference to the drawings. [Brief description of the drawings]
[0018] [Figure 1] FIG. 1 shows a block diagram of a sample processing system according to one embodiment of the present invention.
[0019] [Diagram 2] 1 shows a diagram illustrating different processing paths that can be taken in a sample processing system according to an embodiment of the present invention.
[0020] [Figure 3A]1 shows a high level flow chart illustrating the processing steps performed by a sample processing system according to an embodiment of the present invention.The flow chart illustrates different detection operations that may be performed in the sample processing system. [Figure 3B] 1 shows a high level flow chart illustrating the processing steps performed by a sample processing system according to an embodiment of the present invention.The flow chart illustrates different detection operations that may be performed in the sample processing system.
[0021] [Figure 4A] 1 shows a diagram of an analyzer in a sample processing system according to one embodiment of the present invention.
[0022] [Figure 4B] FIG. 1 shows an exemplary flow chart diagram illustrating an operational procedure for operating the analyzer.
[0023] [Figure 4C] FIG. 1 shows a perspective view of the arrangement of the main sample pipetting station and the sample reservoir of the analyzer.
[0024] [Figure 5A] FIG. 1 shows a top / side cross-sectional view of an incubation carousel, according to one embodiment of the present invention.
[0025] [Figure 5B] 5B shows a top / side perspective view and a cross-sectional view of a portion of the incubation carousel of FIG. 5A.
[0026] [Figure 5C] 5B shows a top perspective view of a portion of the incubation carousel of FIG. 5A.
[0027] [Figure 6A] 1 shows a block diagram of a mass spectrometer.
[0028] [Figure 6B] 1 shows a portion of a mass spectrometer that uses the electrospray method.
[0029] [Figure 6C] 1 shows the structure of an ion detector used in a mass spectrometer.
[0030] [Figure 7A] FIG. 1 shows a diagram of a trap and elution system in a first configuration, according to one embodiment of the present invention.
[0031] [Figure 7B] FIG. 2 shows a diagram of a trap and elution system in a second configuration, according to one embodiment of the present invention.
[0032] [Figure 8] 1 shows a flow chart illustrating an immunopurification process, according to one embodiment of the present invention.
[0033] [Figure 9] 1 shows a flow chart illustrating a protein precipitation process, according to one embodiment of the present invention.
[0034] [Figure 10] 1 shows a flow chart illustrating another immunopurification process according to one embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0035] Embodiments of the present invention may be used to detect the presence, absence, or concentration of an analyte in a biological or chemical sample. Biological samples, such as biological fluids, may include, but are not limited to, blood, plasma, serum, or other bodily fluids or excretions, such as, but not limited to, saliva, urine, cerebrospinal fluid, tears, sweat, gastrointestinal fluid, amniotic fluid, mucosal fluid, pleural fluid, sebum oil, exhaled air, etc. Chemical samples may include any suitable type of sample containing chemicals, including water samples.
[0036] Before discussing embodiments of the present invention, certain terms can be explained in further detail.
[0037] The term "analyzer" may include any suitable instrument capable of analyzing a sample, such as a biological sample. Examples of analyzers include mass spectrometers, immunoanalyzers, hematology analyzers, microbiology analyzers, and / or molecular biology analyzers.
[0038] In some embodiments, the analyzer may be an immunoanalyzer (typically detecting a label (chemiluminescent, electrochemiluminescent fluorescent, radioactive, isotopic, DNA, etc., or a label-free system). Other types of analyzers may include hematology analyzers, microbiology analyzers, chemistry analyzers, urine analyzers, biochemistry analyzers, and / or molecular biology analyzers. When analyzing a biological sample, one or more of these types of analyzers in any suitable combination may be used to analyze the biological sample.
[0039] Hematology analyzers may be used to perform complete blood counts, erythrocyte sedimentation rate (ESR), and / or coagulation tests. Automated cell counters take samples from blood and use both electrical and optical techniques to quantify, classify, and describe cell populations.
[0040] Microbiology analyzers can function as diagnostic tools to determine the identity of biological organisms. In some embodiments, microbiology analyzers can identify infectious microorganisms. Such analyzers can use biochemicals in centrifuge rotors containing different substrates or multiple small sample test microwells in a multi-well panel, depending on the type of test being performed.
[0041] A molecular biology analyzer can be a device that can analyze a biological sample at its molecular level. Examples of molecular biology analyzers can include nucleic acid analyzers, such as DNA analyzers.
[0042] Chemical analyzers may perform assays on clinical samples such as serum, plasma, urine, and cerebrospinal fluid to detect the presence of analytes related to diseases or drugs. Chemical analyzers may use photometry, in which the sample is mixed with an appropriate reagent to produce a reaction that results in a color. The concentration of the analyte determines the intensity of the color produced. The photometer shines light of an appropriate wavelength at the sample and measures the amount of light absorbed, which directly correlates to the concentration of the analyte in the sample. Another analytical method used in chemical analyzers is Na + , K + , Cl - , and Li + The use of an ion selective electrode (ISE) to measure ions such as . An ISE is a sensor that determines the concentration of an ion in a solution by measuring the flow of electric current through an ion selective membrane.
[0043] The term "analyte" may include a substance whose presence, absence, or concentration is determined by embodiments of the present invention. Exemplary analytes may include, but are not limited to, organic molecules, hormones (such as thyroid hormones, estradiol, testosterone, progesterone, estrogen), metabolites (such as glucose or ethanol), proteins, lipids, carbohydrates and sugars, steroids (such as vitamin D), peptides (such as procalcitonin), nucleic acid segments, biomarkers (pharmaceuticals such as antibiotics, benzodiazepines, etc.), drugs (immunosuppressants, narcotics, opioids, etc.), molecules that have a modulatory effect on an enzymatic process, such as, for example, promoters, activators, inhibitors, or cofactors, microorganisms (such as viruses, including EBV, HPV, HIV, HCV, HBV, influenza, norovirus, rotavirus, adenovirus, etc.), bacteria (such as Helicobacter pylori, Streptococcus, MRSA, Clostridium difficile, Lysinella, etc.), fungi, parasites (such as P. pulmosum), cells, cell components (such as cell membranes), spores, nucleic acids (such as DNA and RNA), and the like. Embodiments of the invention may also allow for the simultaneous analysis of multiple analytes in the same or different classes (e.g., simultaneous analysis of metabolites and proteins). In embodiments of the invention, the analysis of a particular analyte, such as a biomarker, may indicate that a particular condition (e.g., disease) is associated with a sample containing the analyte.
[0044] The term "immunoassay" may refer to a laboratory method used to determine the amount of an analyte in a sample. It may be based on the interaction of an antibody with an antigen, and because of the degree of selectivity of the analyte (either the antigen or the antibody), immunoassays may be used to quantitatively determine very low concentrations of the analyte in a test sample. An "immunoanalyzer" may include an instrument in which the immunoassay is automated. A variety of immunoanalyzers are commercially available, including the DxI™ system (Beckman Coulter, CA), the ADVIA™ and CENTAUR™ systems (Siemens Healthcare, Germany), the COBAS™ system (Roche Diagnostic, Germany), the ARCHITEC™ system (Abbott, IL), the VITROS™ system (Ortho-clinical Diagnostic, NJ), and the VIDAS™ system (Biomerieux, France).
[0045] A "mass spectrometer" is an instrument that can measure the mass and relative concentration of atoms and molecules. One example of a mass spectrometer uses elementary magnetic forces on moving charged particles. Essentially, the instrument ionizes the sample and then deflects the ions through a magnetic field based on the mass-to-charge ratio of the ions. Mass spectra can then be used to determine the elemental or isotopic signature of the sample, the mass of the particles and the mass of the molecules, and elucidate the chemical structure of molecules such as peptides and other chemical compounds. Commercially available mass spectrometers can be classified based on how they classify mass selection, including time of flight, quadrupole MS, ion trap (including 3D quadrupole, cylindrical ion trap, linear quadrupole ion trap, orbitrap), Fourier transform ion cyclotron oscillation (FTMS), and the like. Alternatively, they can be classified based on the ion source (laser desorption, matrix-assisted laser desorption, thermal ionization, plasma, spark source, and the like) or detector (electron multiplier (Faraday cup and ion pair photon detector, and the like), inductive detector, and the like). In a preferred embodiment, the mass spectrometer may be a triple quadrupole mass spectrometer.
[0046] In the specific examples provided below, a sample processing system including an immunoanalyzer and a mass spectrometer is described in detail. However, embodiments of the present invention are not so limited. Instead of the immunoanalyzer, another type of analyzer, such as a chemical analyzer, can be used in place of the immunoanalyzer. Many of the functions and features in the immunoanalyzer may also be present in the chemical analyzer (e.g., reagent reservoir, aliquot station, sample preparation station, etc.). Furthermore, additional components, such as a sample introduction device, may also be used in the sample processing system along with the chemical analyzer and mass spectrometer.
[0047] Some embodiments of the invention may include a platform that is fully integrated with a mass spectrometer (measuring mass) and an immunoanalyzer (typically detecting a label (chemiluminescent, electrochemiluminescent fluorescent, radioactive, isotopic, DNA, etc.), or a label-free system). The system may have at least one sample preparation station, which may be separate from or shared with the immunoanalyzer. The system may be integrated with a tracking system and may have the capability of (1) independent analysis by either the immunoanalyzer or mass spectrometer, or (2) serial or parallel analysis by the immunoanalyzer and mass spectrometer. Serial analysis may include either retesting (e.g., the same analyte tested on both analyzers) or replay testing (e.g., a first analyte is tested on one analyzer (typically an immunoanalyzer) and a second or more analytes are tested on the other analyzer (typically a mass spectrometer).
[0048] More specifically, embodiments of the present invention may include an immunoanalyzer integrated into a mass spectrometer. A sample preparation station and sample introduction are also present. The system also includes a control system that may control the mass spectrometer, the immunoanalyzer, at least one sample preparation station, and at least one sample introduction system.
[0049] In some cases, a single sample preparation station is used for both the immunoanalyzer and the mass spectrometer. In other embodiments, there are two sample preparation stations, which may be used exclusively or mutually by the immunoanalyzer and the mass spectrometer. The sample preparation system includes a means for aliquoting the sample (such as an aliquotter), such as an aliquot station including at least one pipetter, a means for holding at least one reagent pack containing reagents required for the immunoassay and / or the mass spectrometer, and a means for transferring reagents from the reagent pack to the aliquoted sample. In some embodiments, the sample preparation station includes a means for holding at least two reagent packs (i.e., one for sample preparation for the immunoanalyzer and one for sample preparation for the mass spectrometer).
[0050] In some embodiments, the sample introduction system is fluidly coupled to at least one of the sample preparation systems. The sample introduction system may include direct flow injection, the use of a trap and elute system (e.g., a trap and elute system including two pumps and a six-port switching valve), the use of an open-port device such as an open-port probe.
[0051] The control system may cause the sample processing system to process a primary sample and provide a result regarding the presence, absence, or amount of a particular analyte in the primary sample. The control system may further cause the sample processing system to process a second sample and provide a result regarding the presence, absence, or amount of one or more analytes in the second sample. The first and second samples may be processed by the same instrument (immunoanalyzer or mass spectrometer) or different instruments (immunoanalyzer and mass spectrometer). The control system may control which reagent pack is used to process the sample (e.g., if it is desired to use mass tags, the control system may instruct the sample preparation system to use a first reagent pack with the first sample aliquot and a different second reagent pack containing mass tags with the second sample aliquot).
[0052] In some embodiments of the invention, mass analysis may be performed after initial testing of a sample using an immunoanalyzer. That is, a mass spectrometer may be used to perform reflex testing of a sample previously processed by an immunoanalyzer. The system and method according to embodiments of the invention also provide the ability to perform automatic reflex testing based on predefined criteria using a control system running intelligent software. Based on whether the results from the primary immunoassay meet certain criteria, the software may determine whether the sample should be retested by an immunoanalyzer or reflex tested by a mass spectrometer. Since the primary sample may still be waiting in the immunoanalyzer, if the control system determines that a retest or reflex test is desirable or necessary, sample preparation for the mass spectrometry assay may be initiated. The sample processing system may advantageously have reagent cartridges for both the optical detection process and the mass spectrometry process.
[0053] In some embodiments, two or more aliquots of the primary sample may be prepared, one for immunoassay analysis and one for mass spectrometry. In some embodiments, after elution of the analytes originally present in the primary sample from the antibodies bound to the magnetic particles, the eluent containing the analytes may be characterized as a processed sample aliquot, since it is derived from the original sample aliquot. The processed sample aliquot may then be analyzed by a mass spectrometer. The primary sample and the processed sample aliquot, as well as any additional sample aliquots, may be temporarily held in a sample storage unit (optionally a refrigerated unit) while the control system determines whether mass spectrometry is required.
[0054] If the control system determines that a retest or reflex process is necessary or desirable, the sample needs to be processed by the mass spectrometer and either the primary sample or a processed sample aliquot may be used. A retest process may be necessary or desirable if the primary analysis is deemed by the control system or other entity to be inconclusive or itself insufficient or incomplete. A reflex test may be necessary or desirable if the primary analysis of the first analyte indicates that further testing of one or more other analytes is desirable.
[0055] Embodiments of the present invention may provide a simplified workflow from sample preparation to final analytical results with multiple options to improve the sensitivity, specificity, and accuracy of the sample analysis process. As mentioned above, embodiments of the present invention may eliminate the need to utilize centrifugation and / or HPLC (high pressure liquid chromatography) (i.e., using high pressure liquid chromatography columns) prior to analysis by mass spectrometer. In some embodiments, centrifuges and HPLC devices are not present in the sample processing system.
[0056] A first exemplary sample preparation procedure that may be performed by the sample preparation system may include immunopurification of the target analyte from the primary sample using monoclonal or polyclonal antibodies attached to paramagnetic particles. In the immunopurification process, after the analyte is captured by the antibody, any unbound molecules are washed away in a washing process. In a subsequent elution step, the analyte is then released from the antibody using a buffer and an eluent. The eluent containing the "purified" target may be characterized as a processed sample aliquot and is then collected and analyzed by a mass spectrometer.
[0057] Antibodies typically used in immunopurification processes can be replaced with alternatives, such as aptamers, nanoparticles, binding proteins, etc. Immunocapture reagents can be designed to capture specific analytes or specific panels of analytes, such as drug panels or endocrine panels. In embodiments of the invention, specific analytes in a panel can be precisely analyzed using an MRM (multiple reaction monitoring) workflow using a triple quadrupole mass spectrometer, where specific parent-daughter ion transitions exist for each analyte. Tandem mass spectrometry or MS 2 If there are no differentiating transitions (typically in the case of isomers or isobars), MS 3 The inherent transitions in can be used to distinguish between them.
[0058] In a second exemplary procedure implemented in the sample preparation system, protein precipitation is used to separate proteins from small molecules. Proteins in a sample aliquot are precipitated using a precipitation reagent, and then the precipitated proteins are bound to paramagnetic beads. The proteins bound to the beads can be physically separated from the supernatant using a magnetic washing process. The supernatant, which can be characterized as a processed sample aliquot, can be collected and transferred to a mass spectrometer for analysis. This workflow can be used to analyze drug classes for definitive or stand-alone testing.
[0059] In some embodiments, mass spectrometry reagents such as mass tags (e.g., Amplifex™ mass tags) may be used during the sample preparation process to enhance the signal and improve sensitivity. Mass tags are typically designed to react specifically with functional groups common to a particular class of analytes, such as the keto functional group present in the steroid class or the diene functional group present in the vitamin D class. Mass tags may affect the fragmentation of molecules to produce specific fragments and provide unique transitions, leading to more accurate results. In some cases, differential electrical mobility of ions in the gas phase may also be used to separate isomeric or isobaric compounds. Such reagents may be used with the second sample aliquot that is processed for mass spectrometry.
[0060] Mass tags can be designed to provide accuracy in a number of ways. First, mass tags may be used to modify the differential electrical mobility of tagged ions (target analytes and interfering compounds) in the gas phase, simplifying their separation based on the difference in their electrical mobility properties. Separating isomeric / isobaric compounds (referred to as interfering compounds) prior to detection can help improve the accuracy of any analytical results. Second, mass tags can also provide signal enhancement of the target analyte to improve sensitivity. Third, mass tags can affect the fragmentation of tagged molecules to help distinguish between analytes and interfering compounds.
[0061] In an embodiment of the invention, an internal standard for the analyte(s) may be added to the sample prior to analysis by the mass spectrometer. The internal standard may be an isotopic version of the analyte(s) to compensate for losses during the sample preparation process. The peak ratio of the internal standard to the analyte may be used for quantification. Quantification may be performed using an external calibration curve, if desired.
[0062] In addition, embodiments of the present invention may use a universal trap column and solvent, as well as a universal mass spectrometry source that may make automation less complicated. The universal trap column and source may work for most assays, without the need to switch between different assays. Software in the control system may indicate when the universal trap column has reached the end of its life and requires replacement.
[0063] 1 shows a high level block diagram of a sample processing system according to one embodiment of the present invention. The sample processing system 100 comprises an analyzer (e.g., an immunoanalyzer) 102, a mass spectrometer 106, and a sample introduction device 104. The sample introduction device 104 may be physically and / or operatively coupled to the analyzer 102 and the mass spectrometer 106, which may in some embodiments form a single instrument. The sample introduction device 104 may serve to transfer a processed sample or a sample aliquot from the analyzer 102 to the mass spectrometer 106. For example, the sample introduction device 104 may be configured to transfer a first or second processed sample aliquot from the analyzer 102 to the mass spectrometer 106.
[0064] The analyzer 102 may include multiple sample aliquot processing devices to form processed sample aliquots for analysis. Such processing devices may process samples or sample aliquots in any suitable manner. Examples of sample aliquot processing devices include reagent addition stations (e.g., reagent pipetting stations), sample pipetting stations, incubators, washing stations (e.g., magnetic washing stations), sample storage units, etc. The multiple sample aliquot processing devices may process a first sample aliquot to form a first processed sample aliquot and may process a second sample aliquot to form a second processed sample aliquot. A "processed sample aliquot" may include a sample aliquot that is processed any suitable number of times by any suitable number of processing devices.
[0065] A control system 108 may also be present in the sample processing system 100. The control system 108 may control the analyzer 102, the sample introduction device 104, and / or the mass spectrometer 106. The control system 108 may include a data processor 108A, a non-transitory computer readable medium 108B, and a data storage device 108C coupled to the data processor 108A. The non-transitory computer readable medium 108B may include code executable by the processor 108A to perform functions described herein. The data storage device 108C may store data for processing samples, sample data, or data for analyzing sample data.
[0066] Data processor 108A may include any suitable data computing device or combination of such devices. An exemplary data processor may include one or more microprocessors that work together to achieve a desired function. Data processor 108A may include a CPU including at least one high speed data processor sufficient to execute program components to execute user requests and / or system generated requests. The CPU may be a microprocessor such as AMD's Athlon, Duron, and / or Opteron, IBM and / or Motorola's PowerPC, IBM and Sony's Cell processors, Intel's Celeron, Itanium, Pentium, Xeon, and / or XScale, and / or similar processors.
[0067] Computer readable medium 108B and data storage device 108C may be any suitable device(s) capable of storing electronic data. Examples of memory may include one or more memory chips, disk drives, etc. Such memories may operate using any suitable electrical, optical, and / or magnetic modes of operation.
[0068] The computer readable medium 108B may include code executable by the data processor 108A to perform any suitable method. For example, the computer readable medium 108B may include code executable by the processor 108A to cause the sample processing system to perform a method including using data from an immunoanalyzer to determine that detection of an analyte in a first processed sample aliquot in the immunoanalyzer is below, above, or equal to a predetermined threshold, and in response to the determination, causing the analyzer to process a second aliquot of the sample to form a second processed sample aliquot and causing the sample introduction device to transfer the second processed sample aliquot from the analyzer to a mass spectrometer, and causing the mass spectrometer to detect the presence of the analyte or another analyte in the second processed sample aliquot. In other embodiments, the computer readable medium 108B may include code executable by the data processor 108A to cause the sample processing system to perform a method including causing the immunoanalyzer to detect an analyte in a first processed sample aliquot and causing the mass spectrometer to detect an analyte in a second processed sample aliquot transferred from the analyzer. In yet other embodiments of the invention, the computer readable medium 108B may include code executable by the data processor 108A to cause the sample processing system to perform a method including using data from the immunoanalyzer to determine that an analyte detected in a first processed sample aliquot at the immunoanalyzer is below or above a predetermined threshold, and in response to the determination, causing the analyzer to process a second aliquot of the sample to form a second processed sample aliquot and causing the sample introduction device to transfer the second processed sample aliquot from the analyzer to the mass spectrometer, and causing the mass spectrometer to detect the presence of the analyte or another analyte in the second processed sample aliquot.In yet another embodiment of the invention, the computer readable medium 108B may include code executable by the data processor 108A to perform a method including directing an aliquot station including at least one pipettor to provide a first sample aliquot of the sample and a second sample aliquot of the sample; directing an analyzer to process a reaction vessel containing the first sample aliquot of the sample to form a first processed sample aliquot and the second sample aliquot of the sample to form a second processed sample aliquot; directing the analyzer to perform a primary analysis of an analyte in the first processed sample aliquot; directing a sample introduction device to transfer the second processed sample aliquot of the sample from the analyzer to a mass spectrometer; and directing the mass spectrometer to perform a secondary analysis of the analyte in the second processed sample aliquot or another analyte in a second process. In yet other embodiments, the computer readable medium 108B may include code executable by the data processor 108A to perform a method including performing a primary analysis of an analyte from a first processed sample aliquot of a first sample aliquot of a sample by a mass spectrometer, and after performing the primary analysis, performing a secondary analysis of the analyte or another analyte in a second processed sample aliquot derived from a second aliquot of the sample by a mass spectrometer or analyzer in the sample processing system.
[0069] When the concentration of the analyte, as detected by the immunoanalyzer, is above, below, or equal to a predetermined threshold, the amount of analyte present can be confirmed and / or quantified by retesting with the mass spectrometer. The predetermined threshold may correspond to a predetermined amount or concentration of the analyte in the first sample aliquot processed. Retesting with the mass spectrometer is particularly useful when the analyte concentration in the sample is above the limit of detection but below the limit of quantification of the immunoanalyzer. Reflection testing with the mass spectrometer is particularly useful when the amount of analyte indicates that further testing of other analytes should be performed (e.g., when one narcotic metabolite is found, it may be desirable to run a panel of other narcotics).
[0070] 2 shows a diagram illustrating different processing paths that may be taken in a sample processing system, according to an embodiment of the present invention. A high level process flow may include a sample preparation processing module 210, a sample introduction processing module 230, and a sample detection processing module 240.
[0071] The sample preparation processing module 210 may include process steps to process a sample containing an analyte so that it may be detected during the sample detection processing module 240. In an embodiment of the invention, the sample preparation processing module 210 may include an immunoprecipitation or immunopurification process. The steps of the sample preparation processing module 210 may be performed in the analyzer 102. The steps of the sample introduction process module may be performed in the analyzer 102 or in the mass spectrometer 106, or may be a separate, stand-alone device separate and apart from the analyzer 102 and mass spectrometer 106. The sample detection process module 240 may be implemented in the mass spectrometer 106 and / or the immunoanalyzer 102.
[0072] The sample introduction process module 230 includes process steps that may transfer a sample containing an analyte from the analyzer 102 to the mass spectrometer 106. The sample introduction process module 230 may also include transfer of a sample without further separation 232 and with further separation 234. Particular sample introduction processes that do not include further separation 232 may include flow injection 232A or SPME (solid phase microextraction) / OPP (open port probe) 232B. Sample introduction processes that may include further separation may include trap and elute process module 234A. An optional DMS (differential mobility spectrometry) process module 238 may be performed downstream of the sample introduction process module 230 after the sample is ionized but before the sample is mass analyzed.
[0073] The direct flow injection process module 232A may utilize an apparatus that may include a direct injection device that may inject the processed sample directly from the analyzer into a mass spectrometer. The apparatus may include a source of carrier solution that may be used to carry the processed sample to the mass spectrometer. A pump, such as a peristaltic pump, may be included in the direct flow injection device.
[0074] The SPME / OPP process module 232B may utilize an SPME device and an OPP apparatus, which may include an open port sampling interface. SPME may integrate sample collection, sample preparation, and extraction into a single solvent-free process. In general, the SPME device utilizes a fiber or other surface (e.g., blade, microtip, pin, or mesh) coated with an extraction phase to which analytes in the sample may preferentially adsorb when the device is inserted into a sample aliquot or a processed sample aliquot. The SPME device may be a vertically aligned coaxial tube arrangement that may be in close proximity to the OPP and allows for the delivery of solvent to the sampling end (open port) through the tube annulus and to be drawn down the central tube into the ion source driven by the nebulizer gas.
[0075] The trap and elute process module 234A may utilize a trap and elute apparatus. The trap and elute process module 234A may include injection of the sample into a small volume column where the analytes of interest are concentrated before elution into a mass spectrometer. The trapping process optimizes sensitivity and selectivity and improves robustness. Schematics of an exemplary trap and elute apparatus are shown in Figures 7A and 7B, which are described in more detail below.
[0076] In other embodiments, a hydrocarbon (e.g., C18) coated tip can be used in place of the trap and elute process module. Such tips are commercially available.
[0077] The sample introduction process module 230 may also include a mechanical reaction vessel transport device, which may include a pick-and-place apparatus, such as a pick-and-place moving gantry, a moving shuttle, such as an extended linear reaction shuttle, or a combination of a pick-and-place moving gantry and an extended linear reaction shuttle.
[0078] The sample detection process module 240 may include steps used to detect the presence, absence, and / or amount of a particular analyte in a sample. The sample detection process module 240 may include the use of a mass spectrometry process module 240A and / or an optical detection process module 240B. The optical detection process module 240B may use chemiluminescence or fluorescence based detection processes. Further details regarding the mass spectrometry process module 240A and the optical detection process module 240B are provided below.
[0079] 3A shows a high level flow chart 300 illustrating different types of detection processes that may be performed using a sample processing system in accordance with an embodiment of the present invention. Flow chart 300 illustrates the ability to detect the presence, absence, and / or concentration of a particular analyte using optical detection and mass spectrometry processes. It is clear that embodiments of the present invention have great flexibility in determining whether an analyte is present or absent in a particular sample.
[0080] In step 302, an aliquot station including at least one pipettor in the analyzer may obtain and distribute two or more or more sample aliquots of a sample into two or more reaction vessels. At least one pipettor in the aliquot station may provide (e.g., distribute) a first sample aliquot of a sample into a first reaction vessel. In step 304, one of the sample aliquots may be subjected to an immunoassay test (an example of a primary analysis). The first reaction vessel including the first sample aliquot may be processed by an immunoanalyzer to form a first processed sample aliquot. The immunoanalyzer may then be used to detect the presence or absence of a particular analyte in the first processed sample aliquot in the reaction vessel.
[0081] After the immunoassay test is performed on the first processed sample aliquot, a control system within the sample processing system may make a decision as to whether a confirmation test is desired in step 306. If a confirmation test is desired, an aliquot station including at least one pipettor may provide a second sample aliquot of the sample. The second sample aliquot in the second reaction vessel may then be processed by an analyzer to form a second processed sample aliquot. The second processed sample aliquot may be transferred from the analyzer to a mass spectrometer in step 314 via a suitable sample introduction device. Once the processed second aliquot is in the mass spectrometer, the mass spectrometer may perform mass spectrometry (an example of a secondary analysis) on the processed second aliquot in step 310. After the mass spectrometry is performed on the processed second sample aliquot, a report may be generated in step 312. If a confirmation test is not desired, then a report may be generated in step 308 without performing mass spectrometry in step 310.
[0082] In some embodiments, data from the immunoanalyzer may indicate that the concentration of the analyte in the first processed sample aliquot is below, above, or equal to a predetermined threshold in the primary analysis. The control system may then determine that a reflex process on the sample may be desirable or necessary. The method may then further include having the analyzer process a second aliquot of the sample to form a second processed sample aliquot. The sample introduction device may transfer the second processed sample aliquot from the analyzer to a mass spectrometer. The control system may then cause the mass spectrometer to detect the presence of one or more other analytes in the second processed sample aliquot in the secondary analysis.
[0083] In some cases, detection of an analyte in a primary analysis may indicate that a particular condition (e.g., a disease state) may be present. However, to confirm that the particular condition is present, a secondary analysis may analyze for a second analyte using mass spectrometry. Together, the presence or absence of the first and second analytes may indicate that the particular condition is present.
[0084] The threshold value may be any suitable value, for example, a threshold value may be that a certain quantity (e.g., amount) or concentration of a particular analyte(s) must be present in a processed sample aliquot before one can conclude with some degree of confidence that the analyte is present or absent in the processed sample aliquot.
[0085] The use of mass spectrometry is desirable in the reflex process. In some cases, testing a sample for an analyte in a conventional immunoanalyzer can result in non-specific binding on the antibodies and / or the magnetic beads to which they are attached. This can affect the accuracy of the analysis performed. Mass spectrometry is not susceptible to the problems associated with non-specific binding and can therefore serve as an effective mechanism for reflex testing or general testing.
[0086] Other methods can also be described with reference to Figure 3B. In a first exemplary method embodiment, a sample preparation module in a sample processing system (e.g., in an analyzer) can generate multiple sample aliquots of a sample in step 322. In step 322, an aliquot station including at least one pipettor or other dispensing device can obtain sample aliquots of one or more samples into one or more reaction vessels. These sample aliquots can be processed as described herein to form processed sample aliquots.
[0087] At step 324, a primary analysis including mass spectrometry testing may be performed on the processed sample aliquot obtained at step 322. After the primary analysis is performed, a report may be generated by the sample processing system in response to the primary analysis at step 322 of the analysis. The presence, absence, or concentration of a particular analyte in the sample may be determined. In some embodiments, the processed sample aliquot may be processed such that one or more analytes in a panel of analytes may be detected if the analyte is present in the sample. The mass spectrometry testing 324 may identify one or more analytes in a panel of analytes in the sample (e.g., multiple potential drugs of abuse, multiple proteins forming a panel, or multiple steroids forming a panel) and / or determine a particular amount of one or more analytes in the sample. The sample processing system may select one or more identified analytes in the sample. At this point, a control system of the sample processing system may cause the sample processing system to test the selected one or more samples according to the secondary analysis.
[0088] In other embodiments, the secondary analysis may be another confirmatory test on the mass spectrometer in step 326. The sample preparation module may process a sample aliquot of the sample and return the processed sample aliquot to the mass spectrometer to perform the secondary analysis including a second mass spectrometry test 326. The secondary analysis may confirm the presence of one or more specific analytes in the sample identified in the primary analysis. After the secondary analysis is completed, a report may be generated in step 334.
[0089] In some embodiments, the secondary analysis may be an immunoassay test (step 328) on one or more selected samples. The sample preparation module may process a sample aliquot of the sample, and the processed sample aliquot may be processed in an immunoanalyzer to perform an immunoassay test 328. The immunoassay test may confirm the presence or amount of one or more analytes identified in the primary analysis. After the secondary analysis, a report may be generated in step 330.
[0090] The process described with respect to FIG. 3B can use mass spectrometry testing to initially screen samples to determine whether a particular analyte or set of analytes may be present in a particular sample. After the initial screening process is complete, a secondary analysis may be performed to provide confirmation regarding the results of the primary analysis. This may be useful when the primary analysis performed is a procedure that has not yet been approved by the appropriate approval body (e.g., FDA, i.e., Food and Drug Administration). In this manner, the method can be used to provide rapid testing of samples for analytes of interest.
[0091] 4A shows a block diagram of an automated immunochemical analyzer 400 that can be used in an automated sample processing system according to an embodiment of the present invention. The basic structure and functional modules of the automated immunochemical analyzer 400 can include a sample presentation unit 401, an aliquot station including a main sample pipetting station 402, a bulk container feeder 403, a first dual reagent pipetting station 404 and 405, a second dual reagent pipetting station 406 and 407, a first pick-and-place gripper 408, a second pick-and-place gripper 409, a third pick-and-place gripper 410, an incubator / washing / reading station 412, a sample reservoir 411, and a reagent reservoir 413. Optionally, the sample and / or reagent reservoirs can be cooled.
[0092] The sample presentation unit 401 can be used to transport the entire required test sample to and from the main sample pipetting station 402. A detailed description of the construction and function of the sample presentation unit 401 is provided in U.S. Patent No. 6,790,413, filed May 3, 2001, which is incorporated herein by reference in its entirety.
[0093] Main sample pipetting station 402 can be used to aspirate samples from sample tubes and distribute them into reaction vessels fed by bulk vessel feeder 403. A detailed description of the construction and function of bulk vessel feeder 403 is provided in U.S. Patent No. 6,790,412, filed February 6, 2001, which is incorporated herein by reference in its entirety.
[0094] The four reagent pipetting stations 404, 405, 406, and 407 may be used to mix samples with reagents for subsequent assays. The four reagent pipetting stations 404, 405, 406, and 407 may be arranged as two dual pipetting stations and may be independent of each other. Each of the four reagent pipetting stations 404, 405, 406, and 407 may have its own fluid pumps and valves, wash towers, reaction vessel carriages, and pipettor(s). Although four pipetting stations 404, 406, 406, 407 are illustrated, it is understood that embodiments of the invention may include more or less pipetting stations.
[0095] Three vessel pick-and-place grippers 408, 409, 410 may be used to transport sample and reaction vessels between various modules of the analyzer. The first pick-and-place gripper 408 may be used to transport reaction vessels between the bulk vessel feeder 403 or sample reservoir 411 and the reagent pipetting stations 404, 405, 406, 407. The second pick-and-place gripper 409 may be used to transport reaction vessels between the reagent pipetting stations 404, 405, 406, 407 and the incubator of the incubator / wash / read station 412. The third pick-and-place gripper 410 is used to transport reaction vessels between the incubator of the incubator / wash / read station 412 and a wash wheel (an example of a wash station). A detailed description of the construction and function of container pick-and-place grippers 408, 409, and 410 is provided in U.S. Patent No. 7,128,874, which is incorporated herein by reference in its entirety. It is understood that embodiments of the present invention may have more or less pick-and-place grippers.
[0096] The sample reservoir 411 may be used to store the sample contained in the reaction vessel at a low temperature for a period of time, for example, up to 3 hours, so that the sample may be retested or used for reflex testing. When a test is requested on a patient sample, the test results may drive a request for additional testing. As mentioned above, this automatic request for additional testing is a reflex test. The time delay from the first aspiration to know if another test is to be initiated may range from 45 minutes or more. To hold the sample tube for such a period of time prevents the sample from being used elsewhere. Once the tube has been passed to another instrument, it may be difficult for a lab technician to find the tube and reload it into an instrument requesting a reflex test. To allow for a single rapid sample draw on a sample tube that may require a reflex test, a single aspiration (aliquot) with enough test material for the possible reflex test(s) may be made. However, the aliquot may need to be refrigerated on the analyzer to ensure that the test material does not evaporate or deteriorate.
[0097] The sample reservoir 411 may be one or more reaction vessels that contain a sample aliquot of the sample being processed in a primary analysis. The sample aliquot stored in the sample reservoir 411 may be used to perform a secondary analysis (e.g., a reflex test) in either an analyzer or a mass spectrometer.
[0098] Referring to FIG. 4C, the arrangement of the main sample pipetting station 402 and the sample reservoir 411 of the automated immunochemical analyzer is shown. The pipettor of the main sample pipetting station 402 first aspirates a sample from a sample tube and then moves to a position above the sample reservoir 411. Meanwhile, the sample reservoir 411 first receives an empty reaction vessel from the bulk container feeder 403 by a pick-and-place gripper 417, which then moves the empty reaction vessel below the pipettor of the main sample pipetting station 402. The aspirated sample is then dispensed into the cooled reaction vessel. Insulators and a door 418 are provided to control the environment within the sample reservoir 411. The sample reservoir 411 may be a precisely controlled refrigerator with multiple storage locations 419 for sample material or capable of receiving and transferring reaction vessels filled with sample material. Sample aliquots may be present in reaction vessels stored in the sample reservoir 411. These samples can be used for retesting or reflex testing in an immunoanalyzer or mass spectrometer.
[0099] The incubator / wash / read station 412 may be used for the incubation, washing, and reading steps of the assay. In some embodiments, the incubator / wash / read station 412 may be characterized generically as a separation station. It may include one or more incubators, one or more assay washing stations, and one or more readers, such as photomultiplier tube (PMT) detectors, or other optical detection systems. A detailed description of the construction and function of the incubator / wash / read station is provided in U.S. patent application Ser. No. 7,217,391, filed Mar. 16, 2001, which is incorporated herein by reference in its entirety.
[0100] As a method to minimize background signals from excess or unbound materials, immunoassays generally use one or more separation phases that are carried out in a reaction vessel. To facilitate the separation or washing process, various techniques can be used, including but not limited to well-coating techniques, bead-coating techniques, or the use of paramagnetic particles. Each of these separation media is coated with a capture reagent (e.g., antibody) that binds the analyte molecules of interest in the sample. When paramagnetic particles are used as the separation medium, they are pulled to the wall of the reaction vessel by a magnet during the washing process, and the supernatant is aspirated. A luminescent label is then bound to these analyte molecules. When a luminescent reagent or substrate is added to the reaction vessel, it reacts with the luminescent label to produce light that can be detected by the optical detection station of the analyzer.
[0101] The reagent reservoir 413 may be used to store reagents used in the immunoassay as well as the mass spectrometry process. In some embodiments, the reagent reservoir may include a plurality of reagent packs, including a first plurality of reagent packs containing reagents for performing the immunoassay and a second plurality of reagent packs containing reagents for performing the mass spectrometry in the mass spectrometer.
[0102] In some embodiments, the reagent packs in the reagent reservoir 413 may contain reagents in liquid or solid form. The reagent reservoir 413 may store the reagent packs in a refrigerated environment until required for use, then transfer the packs to an appropriate reagent pipetting station and return the packs to the reservoir when pipetting is complete. It may also return fully or partially used packs to an operator when required and automatically dispose of empty packs. The temperature in the reagent reservoir 413 may be controlled by a Peltier device and monitored with a thermistor.
[0103] For immunoassays, some types of reagents may include paramagnetic particles with or without antibody or antigen coating, blocking agents, antibodies, assay buffers, antibodies conjugated to enzymes (for chemiluminescence), acids, bases, or sample pretreatment reagents such as releasing agents.
[0104] In the case of mass spectrometry, mass spectrometry reagents such as mass tags (e.g., Amplifex™ mass tags) can be used during the sample preparation process to enhance the signal and improve sensitivity. As described above, such reagents can be used with the second sample aliquot that is processed for mass spectrometry.
[0105] Reagent packs may be loaded into the reagent reservoir 413 as follows: (a) The input tray cover is opened by an operator and, if necessary, the input tray is positioned so that the operator can place a reagent pack in the tray. (b) The input tray cover is closed and the input tray is closed to transport the reagent pack into the reagent reservoir 413. (c) As the input tray closes, each reagent pack position passes a barcode reader (BCR) and each of the four pack positions is read and identified. (d) The reagent pack gripper of the reagent pack transport and sorting mechanism moves to obtain the pack identified by the barcode reader from the input tray. (e) The reagent pack gripper of the reagent pack transport and sorting mechanism moves the reagent pack to either a storage location or a pipetting location (if necessary) and drops the reagent pack. (f) The above steps (d)-(e) may be repeated until all reagent packs are removed from the input tray.
[0106] Reagent reservoir 413 includes mechanisms for transporting and sorting a plurality of reagent packs. A detailed description of the construction and function of such mechanisms for transporting and sorting a plurality of reagent packs is provided in U.S. patent application Ser. No. 6,746,648, filed Jun. 15, 2000. Other structures and functions of reagent reservoir 413 will not be described in detail herein, as they conform to existing arrangements known to those skilled in the art.
[0107] FIG. 4B shows an exemplary flow chart diagram illustrating the basic operational steps of a method for automated immunochemical analysis.
[0108] The basic operating procedures of the automated immunochemical analysis are carried out in three main sections of the automated immunochemical analyzer: a sample collection section 414 where the sample is aspirated from the sample tube and dispensed into a reaction vessel; a reagent pipetting section 415 where the sample is mixed with reagents; and an incubate / wash / read section 416 where the mixed sample is incubated, washed, separated from particles, and read by a photomultiplier tube (PMT) detector or other optical detection station.
[0109] The sample aliquot section 414 and the incubate / wash / read section 416 each have one set of units and operate in one cycle (in one embodiment, a 9 second cycle). The reagent pipetting section 415 may have four independently operating reagent pipetting stations, each of which operates in a second cycle (in one embodiment, a 36 second cycle).
[0110] However, the scheduling of the four reagent pipetting stations may vary (by 9 seconds in one example). For example, the analyzer may accept one test sample every 9 seconds. That is, the analyzer has a 9 second effective cycle. Thus, the analyzer may have a high throughput (e.g., 400 tests per hour). Embodiments of the present invention are not limited to these timings or values.
[0111] 4A and 4B, the basic operating procedures of the sample aliquot section 414, the reagent pipetting section 415, and the incubator / wash / read section 416 are described below.
[0112] A. Operational cycle of sample aliquot section 414
[0113] 1. The user loads the sample presentation unit 401 with a sample rack containing up to four sample tubes.
[0114] 2. The rack is advanced into the main sample pipetting station 402 and the samples may be identified by a barcode reader (BCR) and presented to the main sample pipetting station 402.
[0115] 3. At the same time, the bulk container feeder 403 presents the reaction container required for the test to the sample reaction container movable stage, from which the first pick-and-place gripper 408 picks up the reaction container and stores it in the sample storage section 411 and / or in the reaction container movable stage of any one of the available reagent pipetting stations 404, 405, 406, 407.
[0116] 4. The main sample pipetting station 402 aspirates the required amount of sample and dispenses it into a reaction vessel in the sample reservoir 411. The probe is then washed in its dedicated washing station. Washing the sample probe can reduce sample carryover to a level that does not adversely affect other samples.
[0117] B. Reagent Pipetting Section 415 Operation Cycle
[0118] 1. The first pick-and-place gripper 408 picks up the reaction vessel containing the aliquoted sample and moves it to an available reagent pipetting station.
[0119] The process is described below: (a) a requested reaction vessel in the sample reservoir 411 is positioned under an operating position of the first pick-and-place gripper 408. (b) a reaction vessel carriage of an available reagent pipetting station is positioned under another operating position of the first pick-and-place gripper 408. (c) the first pick-and-place gripper 408 transfers the requested reaction vessel from the sample reservoir 411 to the reaction vessel carriage of the available reagent pipetting station.
[0120] 2. At the same time, the reagent reservoir 413 delivers the required reagent packs to the same reagent pipetting station.
[0121] 3. With the reagent packs and reaction vessels in place, the reagent pipettor at the respective reagent pipetting station aspirates the required volume of sample from the sample reaction vessel and dispenses it into the assay reaction vessel, and retrieves the required volume of reagent from the reagent pack and dispenses it into the assay reaction vessel. The probe is then washed in its dedicated washing station.
[0122] The process of sample aspiration is described below: (a) The reagent pipettor of the reagent pipetting station is positioned above the reaction vessel. (b) Using an ultrasonic level sensing circuit, the surface of the sample is detected and when the surface is found, the descent of the pipettor is stopped and the pipettor is deep enough to draw the required sample volume (thus reducing carryover). (c) The sample is drawn using precision pumps and valves and an in-line pressure profile is collected by using a pressure sensor during sample aspiration and this profile can be used to verify proper sample pick-up. A detailed description of the construction and function of the precision pumps and valves used herein is provided in U.S. Pat. Nos. 6,520,755 and 6,843,481, which are incorporated herein by reference in their entirety.
[0123] The process of reagent aspiration is described below: (a) The reagent pipettor in the reagent pipetting station moves to the location of the appropriate reagent well in the reagent pack. (b) The reagent pipettor lowers into the reagent pack well and, if this is a particle well, the ultrasonic mixing circuit is enabled to mix the particles before aspiration (and the lock signal is checked to ensure proper operation). (c) The reagent is drawn using precision pumps and valves and an in-line pressure profile is collected by using a pressure sensor during reagent aspiration and this profile is used to verify proper reagent pick-up.
[0124] The process of sample or reagent delivery is described below: (a) The reagent pipettor of the reagent pipetting station moves to the location of the assay reaction vessel in the reaction vessel carriage of the pipetting station. (b) The exact dispense height is calculated so that the reagent pipettor is lowered into the assay reaction vessel and just touches the probe after the sample or reagent is dispensed (to ensure that no sample or reagent drops are left at the tip of the probe). (c) The sample or reagent is dispensed using precision piston pumps and valves, and an in-line pressure profile is collected by using a pressure sensor during sample delivery, and this profile is used to verify proper sample or reagent delivery.
[0125] The process of sample dilution is described below: (a) A sample reaction vessel suitable for pipetting is retrieved; (b) A dilution location in the reagent vessel carriage of an available reagent pipetting station is positioned under the operating position of the first pick-and-place gripper 408; (c) A bulk vessel feeder provides two empty vessels (a reaction vessel and a dilution vessel); (d) The first pick-and-place gripper 408 simultaneously transfers both vessels to the reagent vessel carriage of the available reagent pipetting station; (e) The sample is aspirated and delivered to the dilution vessel along with an additional volume of buffer using a precision piston pump and valve, and the exact dispense height is calculated so that the diluted sample just touches the probe after it is dispensed (to ensure that no sample drops are left at the tip of the probe) or is slightly deeper if mixing is required (in such a case the ultrasonic mixing circuit is enabled and the lock signal is checked to ensure proper operation). (f) A specific volume of this diluted sample is aspirated using precision pumps and valves, and an in-line pressure profile is collected using a pressure sensor during aspiration, which is used to verify pickup of the proper diluted sample. (g) The original reaction vessel is returned to the sample reservoir 411 if sample remains, or disposed of if empty. (h) The vessel containing the diluted sample now becomes the reaction vessel for processing the subsequent assay.
[0126] The process of sample and reagent addition is described below: (a) The requested sample is retrieved from the sample reservoir 411; (b) The bulk container feeder supplies an empty reaction vessel to the vessel supply carriage; (c) The vessel supply carriage is positioned under the operating position of the first pick-and-place gripper 408; (d) The reagent vessel carriage of the available reagent pipetting station is positioned under the other operating position of the first pick-and-place gripper 408; (e) The first pick-and-place gripper 408 transfers the empty reaction vessel to the reagent vessel carriage of the available reagent pipetting station; (f) The reagent vessel carriage is positioned for pipetting; (g) The requested reagent pack is also positioned for pipetting; (h) The reagent pipettor of the reagent pipetting station moves to the reagent wash tower to wash the probe and then descends into the reagent wash tower; (i) The sample is aspirated and delivered to the reaction vessel. (j) The reagent pipetter moves to the reagent wash tower and then lowers into the reagent wash tower to wash the probe. (k) The reagent pipetter aspirates the appropriate amount of reagent and delivers it to the reaction vessel. (l) The above steps (j) and (k) are repeated until all of the reagent is delivered to the reaction vessel. (m) If reaction vessel mixing is desired, the probe moves slightly downwards, the ultrasonic mixing circuit is enabled, and the lock signal is checked to ensure proper operation. (n) The reagent vessel mobile platform is positioned under the operating position of the second pick-and-place gripper 409. (o) An empty position on the reagent vessel incubator wheel is positioned under another operating position of the second pick-and-place gripper 409. (p) The second pick-and-place gripper 409 transfers the reaction vessel into the incubator of the incubate / wash / read station 412. (q) In the case of a two-step or three-step assay, the second pick-and-place gripper 409 returns the reaction vessel to the pipetting location, additional reagents are added, and then the vessel is returned by the second pick-and-place gripper 409 to the incubate / wash / read station 412 for a second or third incubation.
[0127] By cleaning the reagent probe, sample and reagent carryover can be reduced to a level that will not adversely affect other samples or reagents. The process is described below: (a) The ultrasonic circuit is enabled to clean the reagent probe. (b) The vacuum pump evacuates the tower while the tower exhaust line pressure is monitored to ensure that the tower is draining properly. (c) The probe is flushed internally with buffer using a precision pump and valves and showered externally using a peristaltic pump. (d) The buffer flow is stopped while the vacuum pump and ultrasonic circuit run a short while longer to ensure that the probe is dry.
[0128] 4. The second pick and place gripper 409 picks up the assay reaction vessel containing the sample and reagent mixture and moves it to the incubator wheel of the incubator / wash / read station 412.
[0129] 5. The first pick and place gripper 408 picks up the sample reaction vessel containing the remaining aliquoted sample and returns it to the sample reservoir 411 if a reflex test is required or ejects it into a waste bin.
[0130] The process is described below: (a) a sample storage location in the sample reservoir 411 is positioned under an operating position of the first pick-and-place gripper 408. (b) a reaction vessel carriage of a reagent pipetting station is positioned under another operating position of the first pick-and-place gripper 408. (c) the first pick-and-place gripper 408 transfers a sample reaction vessel from an available reaction vessel carriage of a reagent pipetting station to the sample reservoir 411.
[0131] C. Incubation / Wash / Read Section 416 Operation Cycle
[0132] 1. The assay vessel remains in the incubator wheel for a programmed time at a controlled temperature using a heating element and monitored with a thermistor, and is then picked up by the third pick and place gripper 410 for cleaning.
[0133] 2. The wash / read ring has multiple aspiration stations and multiple dispensing stations where the assay reaction vessels undergo several operations including particle washing, substrate addition, and incubation under controlled temperature using heating elements and monitored by thermistors.
[0134] 3. The assay reaction vessel is read by a reader / detector and then returned to the incubator by the third pick-and-place gripper 410, after which it is picked up by the second pick-and-place gripper 409 and disposed of in a waste bin.
[0135] The operation of the analyzer is supported by fluidic systems, electronic control hardware, and software, including various sensors and microcontroller(s), power units, motors, and drive mechanisms, and mechanical structures, the determination of suitable materials and structures being within the purview of one skilled in the art.
[0136] The method performed in the automated immunochemical analysis may also include the steps of: (a) adjusting each cycle of at least one of the at least two procedures such that one of the at least two procedures has an operating cycle of a first period and another of the at least two procedures has an operating cycle of a second period, the quotient of the second period divided by the first period being an integer; (b) providing a plurality of independent work stations for performing another of the at least two procedures, each work station operating in a cycle of the second period such that the number of such stations equals an integer; and (c) staggering each cycle of the independent work stations by the first period such that at least one of the work stations is available for each operating cycle of the first period.
[0137] The analyzer has many unique features and advantages. First, the analyzer may have a high throughput, such as 400 tests per hour. Second, the analyzer may provide multiple pipetting modules that can operate independently to ensure uninterrupted analysis even if one of the modules malfunctions. Third, the analyzer may perform retests or reflex tests with a large volume sample storage area.
[0138] Figure 5A shows a cross-sectional view of an incubation carousel 500, Figure 5B shows a cross-sectional view of a portion of the incubation carousel 500, and Figure 5C shows a top perspective view of a portion of the incubation carousel 500, according to one embodiment of the present invention.
[0139] Referring to FIG. 5A, the incubation carousel 500 may include a body including a top 502 in the form of a circular plate having an array of holes 504 for receiving reaction vessels with samples to be processed. Each hole 504 may correspond to a separate incubation area where a reaction vessel may be subjected to an incubation process. The top 502 is mounted on top of a bottom 503 including a plurality of concentric walls 503A (shown in FIG. 5B). The body is located on an axis 510 that may rotate the incubation carousel 500. If necessary, a heater such as a thin film heating element may be incorporated in the body so that the samples in the holes 504 may be heated. The incubator carousel 500 may have shapes other than those specifically illustrated, or more or less holes.
[0140] Magnets 508 may be present in the bottom 503 of the body of the incubation carousel 500. As shown in Figures 5A-5C, magnets 508 are present in the innermost circle of incubation areas, but they may be part of any suitable number of incubation areas. The magnets may be used to bind magnetic particles so that any supernatant suitable for downstream mass analysis may be carried out. The magnets may be permanent magnets or electromagnets. An aspirating device such as a pipetter (not shown) may remove any supernatant and transfer the supernatant to a sample introduction device for eventual transfer to a mass spectrometer.
[0141] A variety of mass analyzer systems that may form part of a mass spectrometer can be used in the sample processing system according to embodiments of the present invention. A suitable mass analyzer system includes two mass separators, with an ion fragmentor disposed in the ion flight path between the two mass separators. Examples of suitable mass separators include, but are not limited to, quadrupoles, RF multipoles, ion traps, time-of-flight (TOF), and TOF with timed ion selectors. Suitable ion fragmentors include, but are not limited to, those that operate on the principles of collision-induced dissociation (CID, also called collision-assisted dissociation (CAD)), photoinduced dissociation (PID), surface-induced dissociation (SID), post-source decay, interaction with an electron beam (e.g., electron-induced dissociation (EID), electron capture dissociation (ECD)), interaction with thermal radiation (e.g., thermal / blackbody infrared radiation dissociation (BIRD)), post-source decay, or combinations thereof.
[0142] Examples of suitable mass spectrometers include, but are not limited to, one or more of a triple quadrupole, a linear quadrupole ion trap (e.g., 4000 Q TRAP® LC / MS / MS System, Q TRAP® LC / MS / MS System), a quadrupole TOF (e.g., QSTAR® LC / MS / MS System), and a TOF-TOF.
[0143] In various embodiments, the mass spectrometer includes a MALDI ion source. In various embodiments, at least a portion of the combined sample is mixed with a MALDI matrix material and subjected to parent-daughter ion transition monitoring using a mass analyzer with the MALDI ion source.
[0144] The mass spectrometer may include a triple quadrupole mass spectrometer for selecting parent ions and detecting their fragment daughter ions. In this embodiment, the first quadrupole selects the parent ion. The second quadrupole is maintained at a sufficiently high pressure and voltage so that multiple low energy collisions occur to fragment some of the parent ions. The third quadrupole is selected to transmit the selected daughter ions to the detector. In various embodiments, the triple quadrupole mass spectrometer may include an ion trap disposed between the ion source and the triple quadrupole. The ion trap may be set to collect ions (e.g., all ions, ions having a particular m / z range, etc.) and transmit the selected ions to the first quadrupole by pulsing the end electrodes to allow the selected ions to exit the ion trap after a fill time. The desired fill time may be determined based on, for example, the number of ions, the charge density in the ion trap, the time between elution of different signature peptides, the duty cycle, the decay rate of excited state species or multiply charged ions, or a combination thereof.
[0145] One or more of the quadrupoles in a triple quadrupole mass spectrometer may be configurable as a linear ion trap (e.g., by adding end electrodes to provide a substantially elongated cylindrical trapping volume within the quadrupole). In various embodiments, the first quadrupole selects a parent ion. The second quadrupole is maintained at a sufficiently high collision gas pressure and voltage so that multiple low energy collisions occur to fragment some of the parent ions. The third quadrupole is selected to trap the fragment ions and, after a fill time, transmit the selected daughter ions to the detector by pulsing the end electrodes to allow the selected daughter ions to exit the ion trap. The desired fill time may be determined based, for example, on the number of fragment ions, the charge density within the ion trap, the time between elution of different signature peptides, the duty cycle, the decay rate of excited state species or multiply charged ions, or a combination thereof.
[0146] In some embodiments, the mass analyzer may include two quadrupole mass separators and a TOF mass analyzer for selecting a parent ion and detecting its fragment daughter ions. In various embodiments, the first quadrupole selects the parent ion. The second quadrupole is maintained at a sufficiently high pressure and voltage so that multiple low energy collisions occur to fragment some of the ions, and the TOF mass analyzer selects the daughter ions to detect, for example, by monitoring ions over a mass range that encompasses the daughter ions of interest and the extracted ion chromatogram that is generated, deflecting ions that appear outside the time window of the selected daughter ions away from the detector, time gating the detector to the arrival time window of the selected daughter ions, or a combination of these.
[0147] In some embodiments, the mass analyzer may include two TOF mass analyzers and an ion fragmentor (e.g., CID or SID, etc.). In various embodiments, the first TOF selects parent ions for introduction in the ion fragmentor (e.g., by deflecting ions appearing outside the time window of the selected parent ion away from the fragmentor), and the second TOF mass analyzer selects daughter ions for detection, for example, by monitoring ions over a mass range encompassing the daughter ions of interest and the extracted ion chromatograms generated, deflecting ions appearing outside the time window of the selected daughter ions away from the detector, time gating the detector to the arrival time window of the selected daughter ions, or a combination thereof. The TOF analyzer may be a linear or reflector type analyzer.
[0148] The mass spectrometer may include a tandem MS-MS instrument including a first field-free drift region having a timed ion selector for selecting parent ions of interest, a fragmentation chamber (or ion fragmentor) for generating daughter ions, and a mass separator that transmits the selected daughter ions for detection. In various embodiments, the timed ion selector includes a pulsed ion deflection plate. In various embodiments, the ion deflection plate may be used as a pulsed ion deflection plate. The mass separator may include an ion reflector. In various embodiments, the fragmentation chamber is a collision cell designed to cause fragmentation of ions and delayed extraction. In various embodiments, the fragmentation chamber may also serve as a delayed extraction ion source for analysis of fragment ions by time-of-flight mass spectrometry.
[0149] In some embodiments, the ionization produces structurally specific fragment ions and Q3 The labeling reagent may be used to generate MRM ions. The labeling reagent may be fully or partially contained in the structurally specific fragment ions. This method may provide both sensitivity and specificity for Q3 MRM ions. In some embodiments, ionization may be used to generate dominant neutral loss fragment ions that may be selected in Q3 and then fragmented to generate structurally specific ions. These fragment ions may then be used for identification and quantification in a procedure called MS3.
[0150] FIG. 6A shows a block diagram of an exemplary mass spectrometer 600 and a sample introduction device 601 coupled to the mass spectrometer. A sample solution may be transferred from an analyzer to the sample introduction device 601. In some embodiments, the sample introduction device 601 may be in the analyzer. The sample introduction device 601 may be coupled to the mass spectrometer 600 via a connecting tube 602. The sample introduction device 601 may introduce the sample solution to an ion source 603 via the connecting tube 602. The ion source 603 may be controlled by an ion source power supply 604 via a signal line 605A. Ions related to sample molecules generated by the ion source 603 are introduced into a mass analysis region 606 and mass analyzed. The mass analysis region 606 is evacuated to a vacuum by a vacuum system 607. The ions thus mass analyzed are detected by an ion detector 608. A detection signal is provided to a data processing unit 609 via a signal line 605B. The data processing unit 609 may be a separate unit or may be part of the control system described above.
[0151] FIG. 6B shows a diagram of a part of a mass spectrometer using the electrospray method. FIG. 6B is a cross-sectional view showing the structure of a sample introduction device 619 connected to an electrospray ion source. The sample solution provided from the sample introduction device 619 is introduced into the capillary 621 for spraying through a connecting tube 622 and a connector 630. By applying a voltage of the order of kV between the spray capillary 612 and the counter electrode 632, small charged droplets of the sample solution are sprayed in a cone shape from the end of the spray capillary. That is, the so-called electrospray phenomenon occurs. In the electrospray method, an outlet 623 for spraying gas is provided so that a gas such as nitrogen gas is poured from the periphery of the spray capillary 621, thereby accelerating the vaporization of the small charged droplets. Furthermore, a gas such as nitrogen gas is blown toward the generated small charged droplets from an exhaust outlet 624 for vaporizing gas provided on the counter electrode 632 side, thereby accelerating the vaporization of the small charged droplets. The ions thus generated are introduced into the vacuum 626 through an ion sampling aperture 625 and are mass analyzed under high vacuum by the mass analysis region 626 .
[0152] FIG. 6C shows the structure of an ion detector. The structure shown in FIG. 6C can be used to improve the signal-to-noise ratio (SIN) in a mass spectrometer. An ion deflection electrode 646 can be provided at the rear of a mass analysis region 648 corresponding to mass separation under a high frequency electric field to deflect mass separated ions. The deflected ions are accelerated with a voltage of the order of kV and collide with a dynode 657 to generate secondary electrons. The secondary electrons are emitted from the secondary electron generating dynode 657 with which the ions collide. The emitted secondary electrons are detected by an electron detector 658 such as an electron multiplier. The structure shown in FIG. 6C prevents neutral molecules with no charge, charged droplets, or droplets with no charge from being detected as a signal by the ion detector 648, thereby achieving an improvement in S / N.
[0153] As mentioned above, a sample introduction device may be disposed between the analyzer and the mass spectrometer. One type of sample introduction device may be a trap and elution device. Details of a suitable trap and elution device may be described with reference to Figures 7A and 7B.
[0154] Figure 7A shows a diagram of components of a trapping and elution device 700 in a first configuration, according to one embodiment of the present invention, and Figure 7B shows the trapping and elution system 700 in a second configuration, according to one embodiment of the present invention.
[0155] The trap and elution apparatus 700 includes a first pump 702 and a second pump 704 in fluid communication with a mixer 706. An injector 708 is downstream of and in fluid communication with the mixer 706. The injector 708 may be interfaced with a series of valves 710. The connection points of the series of valves may be labeled 1-6. The series of valves may be present in a switching valve device 710 that may connect to a trap 712 and may connect or disconnect the trap 712 from a downstream waste station 718 or a downstream mass spectrometer 720. The trap 712 may contain any suitable material, such as a C18 material.
[0156] 7A, a sample to be processed in a mass spectrometer 720 may be pumped by pump A 702 into a mixer 706 and into an injector 708. The sample may then be injected into a series of valves in a switching valve device 710 (connections 1-2, 3-4, and 5-6 may be connected) and may flow through a trap to a waste station. Any analytes of interest may be captured in the trap 712, and any liquid components of the sample not of interest may be transferred to a waste station 718.
[0157] In Figure 7B, a series of valve connections in a switching valve device 710 have been switched. Connections 2-3, 1-6, and 4-5 are now connected. As shown, a buffer compatible with a mass spectrometer 720 may be pumped from a second pump 704 to a mixer 706 and to an injector 708. The injector 708 may then inject the buffer into the trap 712, which elutes any analytes of interest from the trap 712 into the mass spectrometer 720.
[0158] The sample processing system may be capable of performing any suitable analysis on any suitable analyte in any suitable sample. Such analyses may include immunopurification and detection processes, protein precipitation and detection processes, and SISCAPA-type processing methods. Rather than directly measuring intact proteins by mass spectrometry, SISCAPA uses proteolysis (e.g., by the enzyme trypsin) to split the sample proteins into smaller peptides ideally suited for quantification by mass spectrometry. By selecting target peptides whose sequences occur only in the selected target protein (so-called "proteotypic" peptides), the target peptides may serve as direct quantitative surrogates of the target protein. Synthetic versions of the target peptides containing stable isotope labels may be added in known amounts to the digested sample to serve as internal standards (SIS). As the target peptides and SIS are chemically indistinguishable throughout the workflow, they may be measured separately by the mass spectrometer due to the mass difference of the stable isotope labels, and their ratio provides the desired quantitative estimate of the target peptide amount.
[0159] 8-10 show a process utilizing an analyzer to prepare a sample for mass analysis and the subsequent mass analysis performed by the mass spectrometer.
[0160] Figure 8 shows a flow chart illustrating an immunopurification process according to one embodiment of the present invention, which can be referenced with respect to the analyzer diagram of Figure 4A above.
[0161] In step 802, a sample in a sample tube is loaded into a sample presentation unit 401 in an analyzer 400. The sample tube may be present with a number of other sample tubes in a sample tube rack or other sample tube carrier.
[0162] In step 804, the main sample pipetting station 402 may then pipette one or more aliquots of the sample in the sample tube into one or more reaction vessels provided by the bulk vessel feeder 403. At this point, the first pick-and-place gripper 408 may transfer the reaction vessel to the reagent pipetting stations 404, 405, 406, 407. If two sample aliquots are present in two reaction vessels, one of the reaction vessels may be transported by the first pick-and-place gripper 40 to the sample reservoir 412 for possible further reflex testing or retesting by either an immunoanalyzer or a mass spectrometer. In some cases, a single reaction vessel with a sample aliquot may be stored in the sample reservoir 412 or may be used for multiple tests (e.g., by taking a secondary aliquot from the reaction vessel and transferring it to a third vessel). In some cases, 5-10 tests may be performed from the initial aliquot in the reaction vessel.
[0163] In step 806, magnetic beads coated with analyte-specific capture antibodies may be added to the sample aliquot in the reaction vessel along with any other suitable reagents in one of the reagent pipetting stations 404, 405, 406, 407. The reagents and sample aliquot may then be mixed in the reagent pipetting station. Mixing may be performed by aspirating and dispensing fluids in the reaction vessel using a pipettor, or by any other suitable mixing process. Also, it should be noted that while the reagents are described as being pipetted in this and other examples, it is understood that the reagents may be added to the reaction vessel in any suitable manner. For example, dry reagents may be present in or added to the reaction vessel before or after the sample aliquot is added thereto.
[0164] After the appropriate reagents have been added to the reaction vessel containing the sample aliquot, a second pick-and-place gripper 409 may transfer the reaction vessel to an incubator / wash / read station 412 .
[0165] In step 808, the reaction vessel containing the magnetic beads and sample may be incubated in an incubator within incubator / wash / read station 412 to capture any analytes of interest with the antibodies attached to the magnetic particles. The mixture within the reaction vessel may be incubated for any suitable amount of time (e.g., 60 minutes).
[0166] In step 810, the magnetic beads may be washed with a wash fluid and magnetically separated from the supernatant in a washing device of the incubator / wash / read station 412. A pipettor in the washing device may be used to dispense and remove any fluids from the reaction vessels to carry out this process.
[0167] Once the washing process is complete, a second pick-and-place gripper 409 may then transport the reaction vessel to the reagent pipetting stations 404, 405, 406, 407. Once the analytes of interest are bound to the antibodies on the magnetic particles, the control system may determine whether an immunoassay detection process or a mass spectrometry process is performed. In some cases, the decision as to whether an immunoassay detection process or a mass spectrometry process is performed may be made early in the process.
[0168] If an immunoassay detection process is performed, one of the pipetting stations 404, 406, 407 may dispense a chemiluminescent substrate or other optical substrate into the reaction vessel. Alternatively, the substrate may be added to the reaction vessel by a dedicated pipettor in the washing system. The reaction vessel may then be transferred by a second pick-and-place gripper 409 to an incubator in the incubator / wash / read station 412. In the incubator, the chemiluminescent substrate may bind to the analyte of interest that is still bound to the magnetic beads. The reaction vessel may then be transferred from the incubator to a reader in the incubator / wash / read station 412 using a third pick-and-place gripper 410. The reader may then detect whether the analyte is present and / or the concentration of the analyte.
[0169] In some embodiments of the invention, the detection process may be performed by a mass spectrometer. Steps 812, 814, 816, 822, 824, 826, and 828 may be performed when a mass spectrometer is used to detect the presence or concentration of an analyte in a sample.
[0170] In step 812, instead of adding one or more optical detection reagents (e.g., chemiluminescent substrates) into the reaction vessel, one of the reagent pipetting stations 404, 405, 406, 407 may add an elution buffer to the reaction vessel containing the processed sample. The reagent pipetting station may then mix the bound elution buffer with the magnetic particles containing the bound analyte. After this step is performed, the second pick-and-place gripper 409 may then transfer the reaction vessel to an incubator in the incubator / wash / read station 412.
[0171] In step 814, an incubation process may be carried out in an incubator in the incubator / wash / read station 412. The mixture in the reaction vessel may be incubated for any suitable period of time.
[0172] In step 816, a magnetic separation process may be performed in a wash station within the incubator / wash / read station 412 to separate the supernatant from the magnetic particles. Alternatively, as described above, the magnetic separation process may be performed in the incubator within the incubator / wash / read station 412 if the incubator includes an incubation area with a magnet. In other cases, a magnet in either the wash station or the incubator within the incubator / wash / read station 412, or even in one of the pipetting stations 404, 405, 406, 407, may confine the magnetic particles to a location within the reaction vessel.
[0173] In step S822, the supernatant containing the analyte of interest in the reaction vessel may be transferred to a second reaction vessel using a pipettor adjacent to the incubator / wash / read station or any other suitable location, leaving the magnetic particles in the first reaction vessel.
[0174] In step 824, the second reaction vessel or the supernatant containing the analyte of interest may be transferred to a mass spectrometer using one or more of the sample introduction devices.
[0175] Optionally, at this point in the process, one or more mass tags or derivatizing agents may be added to the supernatant containing the analyte of interest. The mass tags or derivatizing agents may be added by one or more of the reagent pipetting stations 404, 405, 406, 407.
[0176] In step 826, once the supernatant containing the analytes of interest is in the mass spectrometer, mass analysis can be performed.
[0177] In step 828, data analysis may be performed by a mass spectrometer, as described above.
[0178] Figure 9 shows a flow chart illustrating a protein precipitation process according to one embodiment of the present invention. In the protein precipitation process, proteins in a sample that are not of interest can be bound to magnetic particles. The magnetic particles can be separated from the supernatant containing the analyte of interest in a reaction vessel. The analysis illustrated in Figure 9 can be performed in place of an immunoassay process or as a reflex test of a previous immunoassay process.
[0179] In step 902, a sample in a sample tube is loaded into a sample presentation unit 401 in the analyzer 400. The sample tube may be present with a number of other sample tubes in a sample tube rack or other sample tube carrier.
[0180] In step 904, the main sample pipetting station 402 may then pipette the mixture of sample aliquots containing paramagnetic microparticles, assay standards, and precipitation buffer into reaction vessels provided by bulk vessel feeder 403. The mixture in the reaction vessels may then be mixed at the main sample pipetting station using multiple dispense and aspiration steps, or using any other suitable mixing process.
[0181] At this point, a second pick-and-place gripper 409 may transfer the reaction vessel to an incubator / wash / read station 412 .
[0182] In step 906, the reaction vessel containing the mixture may be incubated in an incubator within the incubator / wash / read station 412 so that any protein matrix within the sample aliquot binds to the paramagnetic microparticles.
[0183] In step 908, the paramagnetic microparticles with the binding protein matrix are magnetically separated from the supernatant containing the analyte of interest in a washing device within the incubator / wash / read station 412. Alternatively, the magnetic separation process can be performed in an incubator within the incubator / wash / read station 412 if the incubator includes an incubation area with a magnet, as described above.
[0184] In step 910, the supernatant containing the analyte of interest in the reaction vessel may be transferred to a second reaction vessel provided by the bulk vessel feeder 403 using a pipettor adjacent to the incubator / wash / read station 412.
[0185] In step 914, once the supernatant containing the analytes of interest is in the mass spectrometer, mass analysis can be performed.
[0186] In step 916, data analysis may be performed by a mass spectrometer.
[0187] In some embodiments, instead of performing steps 908, 910, and 912, the analyzer may transfer the reaction vessel to a centrifuge module (which may be located within the analyzer, mass spectrometer, or may be separate from them), spin it, and then return it to the analyzer.
[0188] Figure 10 shows a flow chart illustrating another immunopurification process according to one embodiment of the present invention. The process illustrated in Figure 10 may be a SISCAPA type processing method as described above.
[0189] In step 1002, a sample in a sample tube is loaded into a sample presentation unit 401 in an analyzer 400. The sample tube may be present with a number of other sample tubes in a sample tube rack or other sample tube carrier.
[0190] In step 1004, the main sample pipetting station 402 may then pipette the sample aliquots in the sample tubes and the modifying / alkylating reagents into reaction vessels provided by the bulk vessel feeder 403. The first pick-and-place gripper 408 may then transfer the reaction vessels to an incubator in the incubator / wash / read station 412 so that an incubation process can be performed.
[0191] In step 1006, the reaction vessel containing the sample is incubated.
[0192] After incubation, a second pick-and-place gripper 409 may transfer the reaction vessels to the reagent pipetting stations 404 , 405 , 406 , 407 .
[0193] In step 1008, one of the reagent pipetting stations 404, 405, 406, 407 may add trypsin and mix the resulting mixture in the reaction vessel. A second pick-and-place gripper 409 may then transfer the reaction vessel to an incubator in the incubator / wash / read station 412.
[0194] At step 1010, an incubation process may be performed in the incubator in the incubator / wash / read station 412. At this point, the second pick-and-place gripper 409 may transfer the reaction vessel to one of the reagent pipetting stations 404, 405, 406, 407.
[0195] In step 1012, one of the reagent pipetting stations 404, 405, 406, 407 may add magnetic microparticles coated with antibodies and SIS peptides. After this step is performed, the second pick-and-place gripper 409 may then transfer the reaction vessel to an incubator in the incubator / wash / read station 412.
[0196] In step 1014, a magnetic separation and washing process may be performed in a washing device in the incubator / washing / reading station 412. Once this process step has been performed, the second pick-and-place gripper 409 may then transport the reaction vessel to the reagent pipetting stations 404, 405, 406, 407.
[0197] In step 1016, one of the reagent pipetting stations 404, 405, 406, 407 may add an elution buffer and then mix the elution buffer with the magnetic particles containing the bound analyte. After this step is performed, the second pick-and-place gripper 409 may then transfer the reaction vessel to an incubator in the incubator / wash / read station 412.
[0198] In step 1018, an incubation process may be carried out in an incubator in the incubator / wash / read station 412.
[0199] In step 1020, the magnetic separation process may be performed in a wash station within the incubator / wash / read station 412. Alternatively, as described above, the magnetic separation process may be performed in the incubator within the incubator / wash / read station 412 if the incubator includes an incubation area with a magnet.
[0200] In step 1022, the supernatant containing the analyte of interest in the reaction vessel may be transferred to a second reaction vessel using a pipettor adjacent to the incubator / wash / read station.
[0201] In step 1024, the second reaction vessel or the supernatant containing the analyte of interest may be transferred to a mass spectrometer using one or more sample introduction devices.
[0202] In step 1026, once the supernatant containing the analytes of interest is in the mass spectrometer, mass analysis can be performed.
[0203] In step 1028, data analysis may be performed by a mass spectrometer.
[0204] An integrated sample processing system according to embodiments of the present invention may be used to measure or determine the presence of a variety of analytes, such as hormones, drugs of abuse, and tumor markers, in one or more samples.
[0205] Non-limiting examples of drugs of abuse that may be measured include amphetamines, barbiturates, benzodiazepines, opiates, oxycodone, cocaine, methadone, EDDP, THC, and buprenorphine. Samples for drug testing are typically urine or oral fluids such as saliva. In some embodiments, the sample is first measured in an analyzer, such as a chemical analyzer or immunoanalyzer, to generate a measurement result. The result is then input to a control system that compares the result to one or more predefined assay thresholds. If the measurement result exceeds (e.g., exceeds) one or more thresholds, the control system may determine that the sample contains a drug of interest. If the measurement result does not exceed one or more thresholds, the control system may determine that the specimen does not contain a drug. In some embodiments, if the result from the analyzer is positive for a particular drug, the control system then requests a second aliquot of the sample to be taken and a confirmatory test by mass spectrometry (MS). If one or more of the drugs are listed above, the criteria specified in the Mandatory Guidelines for Federal Workplace Drug Testing Program published by the Substance Abuse and Mental Health Services Administration (SAMHSA) Federal Register (82 FR Vol. 82, 7920, 7942 (2017)) may be used.
[0206] Non-limiting examples of hormones that may be analyzed in a sample may include aldosterone, plasmarenin aitivty, cofactor, cortisone, corticosterone, luteinizing hormone, cortisol, androstenedione, methylmalonic acid, homocystine, progesterone, DHEAS, estradiol / 17-β-estradiol, estrone, testosterone, 11-deoxycortisol, 17-hydroxyprogesterone, pregnenolone, and 17-hydroxypregnenolone. In some embodiments, the levels of certain hormones may vary significantly depending on gender and age. For example, the amount of testosterone is 10 times higher in men than in women. Immunoanalyzers typically have limited sensitivity compared to mass spectrometry, so for certain demographic groups where the target hormones are known to be in low concentrations, these hormones may be tested directly in the mass spectrometer. In some embodiments, when patient demographic information is not available, typically an analyzer such as an immunoanalyzer may be used as an initial test. For samples shown to have very low levels of the target hormone (e.g., below a predetermined threshold such that the immunoanalyzer cannot accurately measure the concentration), the control system may call for a reflex test by the mass spectrometer to accurately measure the concentration of the target hormone in the sample.
[0207] Non-limiting examples of tumor markers that may be measured using the integrated sample processing system disclosed herein include lipase, alpha-fetal protein, CA 125, CA 15-3, CA19-9, CA 27-29, CEA, β hCG+hCG, parathyroid hormone. In some embodiments, the panel may include 10-500, e.g., 20-100, 30-400, or 50-200 known tumor markers. To assay a large panel of analytes, such as tumor markers, mass spectrometry is first used as a screening assay to identify a subset of markers that are positive for the sample, and then a chemistry / immunoanalyzer is used to confirm that these markers are positive. The combination of these two technologies offers the inherent advantages of rapid marker identification and authentication, since mass spectrometers may be particularly suitable for multiplex testing, but may not be government (e.g., FDA) approved diagnostic methods, and immunoassay tests may be government (e.g., FDA) approved tests, but the cost of running the mass spectrometry may be low.
[0208] Working Example
[0209] Exemplary Sample Collection Methods
[0210] The integrated sample processing system disclosed herein can be used to measure analytes from a variety of bodily fluids, such as serum, plasma, and urine. The following description includes details of several sample collection methods and is exemplary and not limiting.
[0211] Serum samples may be prepared from whole blood drawn from a subject. The blood sample may be allowed to sit at room temperature for 15-30 minutes to allow clotting. The sample is then centrifuged at 1,000-2,000g in a refrigerated centrifuge for at least 15 minutes. The supernatant, which is serum, may be immediately transferred with a sterile pipette to a clean vial. Serum samples may be maintained at 2-8°C during handling. If the serum is not analyzed immediately, it may be stored at -20°C or below until use. Repeated freeze-thaw cycles may be avoided, as they may be detrimental to many serum components and may affect the accuracy of the assay.
[0212] Plasma samples can also be prepared from a whole blood sample from a subject. Whole blood can be drawn and collected in tubes treated with an anticoagulant such as heparin. Cells can be removed from the plasma by centrifugation at 1,000-2,000 x g for 10 minutes using a refrigerated centrifuge. The resulting supernatant is plasma and can be immediately transferred with a sterile pipette into a clean vial. Handling and storage of plasma samples can be the same as serum samples, as described above.
[0213] Urine samples may be collected according to SAMHSA guidelines (Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention), available at https: / / www.samhsa.gov / sites / default / files / specimen-collection-handbook-2014.pdf.
[0214] Example 1: Testosterone
[0215] A sample processing system according to an embodiment of the present invention may be used to measure testosterone in a biological fluid sample. Male testosterone is secreted by Leydig cells in adults and is controlled by luteinizing hormone (LH). Abnormally low total testosterone levels in men may indicate hypogonadism, hypopituitarism, hyperprolactinemia, renal failure, liver cirrhosis, or Klinefelter's syndrome. High total testosterone values in men may be due to adrenal and testicular tumors, congenital adrenal hyperplasia, or abnormalities in the hypothalamic-pituitary-testicular axis. In women, testosterone is produced in the ovaries, adrenal glands, and peripheral adipose tissue. Increased female total testosterone levels may indicate polycystic ovary syndrome (PCOS), interstitial theca cell hyperplasia, ovarian and adrenal tumors, congenital adrenal hyperplasia, and other disorders of the hypothalamic-pituitary-ovarian axis. Thus, there is a need to monitor testosterone levels in both men and women. MS is often the preferred method for measuring testosterone in women, because women typically have about 10 times lower serum concentrations than men, and immunoanalyzers are often insufficiently sensitive to reliably measure very low levels of testosterone. However, in some cases, demographic information (e.g., the subject's gender) is not available at the time of testing. Thus, in some embodiments, initial testing is performed by an immunoanalyzer. If the immunoanalyzer indicates low testosterone levels below the detection range in a particular sample, the control system may then request a confirmatory test using MS.
[0216] For initial testing of testosterone in biological samples, the Access Testosterone Assay Kit (commercially available from Beckman Coulter, Inc., Brea, Calif.) can be used. The assay can be run on an immunoanalyzer of a sample processing system. The Access Testosterone Assay is a competitive binding immunoenzymatic assay that uses paramagnetic particles coated with mouse monoclonal anti-testosterone antibodies, testosterone alkaline phosphatase conjugates, and goat anti-mouse polyclonal antibodies. Testosterone in the sample is released from the carrier protein and competes with the testosterone alkaline phosphatase conjugate for binding sites on a limited amount of specific anti-testosterone monoclonal antibody. The resulting antigen-antibody complex is then bound to a solid phase by a capture antibody. After incubation in a reaction vessel, materials bound to the solid phase are retained in a magnetic field while unbound materials are washed away. The chemiluminescent substrate Lumi-Phos is then added to the solid phase and the resulting complex is then bound to the solid phase. * 530 is added to the vessel and the light produced by the reaction is measured with a luminometer. Light production is inversely proportional to the concentration of testosterone in the sample. The amount of analyte in the sample is determined from a stored multi-point calibration curve.
[0217] In the first test, a serum sample is obtained from a first subject with no demographic information available (age, sex, etc.), loaded into the system sample preparation module in the immunoanalyzer, and prepared using the Access Testosterone Assay Kit described above. An immunoassay is run on the immunoanalyzer. The results of the immunoassay, which may include serum testosterone amount, are transmitted to a control system of the immunoanalyzer which compares the measurements to a reference range for serum testosterone, i.e., a range of concentrations in healthy individuals. For men ages 18-66, the reference serum testosterone level is typically 1.75-7.81 ng / mL, and for women, the reference serum testosterone level is typically less than 0.1-0.75 ng / mL. The attending physician can determine a threshold value, and the results from the immunoanalyzer are considered accurate if they are above that threshold. If the patient has an amount of testosterone below the threshold, the control system in the immunoanalyzer can then cause a second aliquot from the sample to be prepared as described above. The threshold value may vary depending on the level of precision and accuracy required for the test, but is typically a value in the range of 2 to 0.1 ng / mL, e.g., 1.75 ng / mL or 0.8 ng / mL. A second aliquot of the sample may then be processed (as described above). The processed sample is then transferred to a mass spectrometer in the sample processing system and injected into the mass spectrometer. The mass spectrometer then determines the amount or concentration of testosterone in the serum sample. The results of the tests performed by the immunoanalyzer and mass spectrometer may then be reported.
[0218] In a second exemplary test, a serum sample may be obtained from a second subject. The second subject's medical records may be accessible and may indicate that the subject is female. This information may be transmitted to a control system within the sample processing system, which determines that the sample should be analyzed only by the mass spectrometer and not necessarily by the immunoanalyzer. The control system then causes a sample aliquot to be prepared and processed. The processed sample aliquot is then injected into the mass spectrometer as described above. The mass spectrometer then measures the amount of testosterone in the serum sample of the second subject. The measurements from the mass spectrometer are then reported.
[0219] Example 2: Amphetamines
[0220] The sample processing system according to the embodiment of the present invention can be used to test for addictive drugs. One exemplary addictive drug type is amphetamine. Amphetamine is a central nervous system stimulant that produces wakefulness, alertness, increased energy, reduced hunger, and an overall feeling of well-being.
[0221] Amphetamine appears in urine within 3 hours after any type of dose and can be detected by the EMIT® II+ Amphetamine Assay (commercially available from Backman Coulter, Inc., Brea, CA) for as long as 24-48 hours after the last dose. The EMIT® II+ Amphetamine Assay is a homogeneous enzyme immunoassay. The assay is based on competition between the drug in the sample for antibody binding and the drug labeled with the enzyme glucose-6-phosphate dehydrogenase (G6PDH). Since enzyme activity decreases upon binding to the antibody, the drug concentration in the sample can be measured in terms of enzyme activity. The active enzyme converts nicotinic acid adenine dinucleotide (NAD) to NADH, resulting in a change in absorbance that is measured spectrophotometrically. The coenzyme NAD functions only with the bacterial (Leuconostoc mesenteroides) enzyme used in the assay, so endogenous serum G6PDH does not interfere.
[0222] Reagents used in the test may include mouse monoclonal antibodies against d-amphetamine (61 μg / mL) and d-methamphetamine (10 μg / mL), glucose-6-phosphate (5.5 mM), nicotinic acid adenine dinucleotide (3.5 mM), bovine serum albumin, amphetamine labeled with bacterial G6PDH (0.72 U / mL), Tris buffer, preservatives, and stabilizers.
[0223] For drug testing, urine samples can be collected according to SAMHSA guidelines (Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention), available at https: / / www.samhsa.gov / sites / default / files / specimen-collection-handbook-2014.pdf. Urine samples are typically submitted to a certified laboratory within 24 hours of collection. The urine sample is prepared in a sample preparation module within the sample processing system. Reagents are added to the sample to be tested and an immunoassay is performed on an immunoanalyzer. The results are then entered into a control system within the sample processing system. The control system then compares the results to an assay threshold. If the amount is above the threshold, e.g., 300 ng / mL, the control system determines that the sample contains amphetamine, as a preliminary reading. If the amount is below the threshold, the control system determines that the specimen does not contain amphetamine.
[0224] If the result from the analyzer is positive, the control system then calls for a confirmatory test to be performed by the mass spectrometer. A second aliquot of the sample is then taken and prepared for the mass spectrometer as described above. Calibration standards and controls containing amphetamine are purchased from Cerilliant, Inc. and Utak Laboratories, Inc. If the mass spectrometry measurement indicates that the second processed sample aliquot contains amphetamine, the subject is identified as positive for amphetamine and a report is generated.
[0225] Example 3 Tumor marker panel
[0226] The integrated sample processing system can also be used for cancer diagnosis. Mass spectrometry is useful for multiplex testing and can therefore be used to test large panels of tumor antigens, such as a panel with hundreds of known tumor markers. In one example, a tumor panel includes lipase, alpha-fetal protein, CA125, CA15-3, CA19-9, CA27-29, CEA, Beta hCG+hCG, and parathyroid hormone. However, mass spectrometry may not be a government-approved diagnostic method in some jurisdictions. In such cases, confirmatory testing can be performed by an immunoanalyzer in the sample processing system to confirm the initial determination made by the mass spectrometer.
[0227] To test the tumor panel, a plasma sample is prepared as described above. A first aliquot of the plasma sample is prepared as described above and sent to a mass spectrometer. The results are returned to a control system in the sample processing system, which compares the measurements with predefined thresholds to determine whether any of the tumor markers are positive in the sample (i.e., the measurement(s) exceed the threshold(s) for a particular marker(s)).
[0228] If a small subset of tumor markers is indicated as positive according to the mass spectrometer data, the control system in the sample processing system then instructs the sample preparation module in the immunoanalyzer to prepare and process a second aliquot of the sample. The immunoanalyzer then detects the subset of tumor markers using a multiplex fluorescence-based sandwich immunoassay. The assay may involve the addition to the sample aliquot primary antibodies specific for each tumor marker in the subset, and detection antibodies conjugated to fluorophores, capable of recognizing each of the primary antibodies. The fluorophores have different excitation and emission wavelengths such that the fluorescent signals from the detection antibodies do not interfere with each other. A fluorescent signal is measured from each of the detection antibodies, representing the respective amount of the corresponding tumor marker in the sample. The results of the tumor markers determined to be positive by the immunoanalyzer are then reported.
[0229] The above description is illustrative and not limiting. Many variations of the present invention will become apparent to those skilled in the art upon review of this disclosure. Thus, the scope of the present invention should not be determined with reference to the above description, but should instead be determined with reference to the appended claims, along with their full scope or equivalents.
[0230] One or more features from any embodiment may be combined with one or more features of any other embodiment without departing from the scope of the invention.
[0231] The specification of "a," "an," or "the" is intended to mean "one or more," unless specifically indicated to the contrary.
[0232] All patents, patent applications, publications and the above descriptions are incorporated herein by reference in their entirety.
Claims
1. 1. A method performed by a sample processing system, the sample processing system comprising an analyzer, a mass spectrometer, a sample introduction device, and a control system, the control system operatively coupled to the analyzer, the mass spectrometer, and the sample introduction device, the method comprising: performing, by the analyzer, a primary analysis of an analyte in a first processed sample aliquot derived from a first sample aliquot of a sample in a reaction vessel; determining whether a concentration of an analyte in the first processed sample aliquot is below, above, or equal to a predetermined threshold; transferring a second processed sample aliquot derived from a second sample aliquot of the sample from the analyzer to the mass spectrometer by the sample introduction device; performing a secondary analysis of the analyte or another analyte in the second processed sample aliquot by the mass spectrometer in a secondary analysis; A method comprising:
2. The method of claim 1 , wherein the analyzer includes two or more of a pipetting station, a reagent dispensing station, an incubator, and a washing and separation station.
3. The method of claim 1 , wherein the analyzer is an immunoanalyzer.
4. Processing the first sample aliquot comprises: dispensing a reagent into a reaction vessel containing the first sample aliquot; incubating the reaction vessel containing the reagent and the sample aliquot; separating the analyte from other components in the first sample aliquot using a washing and magnetic separation process; The method of claim 1 , comprising:
Citation Information
Patent Citations
Uniform velocity rotary three-leg joint
JP1983000628A
Compositions, methods, and kits for quantifying target analytes in samples
JP2014522496A
A method for selecting or excluding cancer patients to be treated with immune response-inducing therapies using mass spectrometry.
JP2015528110A
Automatic analysis device and analysis method
JP2016156675A
Analysis device and analysis method
WO2016006398A1
